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The treatment of rotator cuff tears of the shoulder is one the most common and challenging
orthopedic problems. Tendon tears not only lead to pain but can also cause tendon thinning and
retraction, fatty expansion and muscle atrophy. This subsequently can result in loss of shoulder
stability and function. Clinically, surgical repair of tendons is performed to restore the connection
between bone, tendon, and muscle. However, even after surgical repair, compromised tendon
healing can be observed mainly due to fatty expansion into adjacent muscles. Preventing adjacent
muscle degeneration and addressing fatty expansion is therefore critical to achieving favorable
clinical outcomes after tendon repair.
Among different approaches, the application of electrical cues has shown to promote muscle
functional regeneration. The goal of this study was to engineer novel electrically conducting
polymer matrices, which could help to retain muscle quality and enhance muscle regeneration after
rotator cuff repair. Matrices were prepared by coating different concentrations of poly
(3,4ethylenedioxythiophene): poly (styrenesulfonate) (PEDOT: PSS) (1%, 10%, 33%, 100%) on
polycaprolactone

(PCL) electrospun

nanofiber

matrices.

The

electrical

conductivity,

biocompatibility and the ability of the matrices to support muscle cell adhesion, proliferation and
differentiation were studied using in vitro techniques. In vivo studies using rat rotator cuff acute
and chronic repair models found that aligned electroconductive muscle matrices could guide and
stimulate muscle regeneration, thereby suppressing fatty expansion.
In summary, the study examined the feasibility of novel electroconducitve matrices to achieve
high levels of muscle regeneration in the setting of rotator cuff tears.
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CHAPTER 1 INTRODUCTION
1.1 Introduction
Skeletal muscle is a critical component of the human body, consisting of 40-45% of an adult's
body mass [1]. It is mainly responsible for generating forces which facilitate voluntary
movement and locomotion [2]. When a moderate injury occurs, skeletal muscle has a robust
ability to regenerate through the activation of muscle progenitor cells, also termed as satellite
cells [3]. These satellite cells play a vital role in muscle regeneration as they not only participate
during myogenesis but can also undergo a self-renewal process to maintain an undifferentiated
population in the tissue niche [4]. Briefly, in response to injury, those quiescent satellite cells are
activated. They will undergo proliferation, differentiate into myoblasts and further fuse to form
multinucleated myofibers. These myofibers will then integrate into the functional muscle tissue
[5].
However, there is a limit to regeneration through satellite cell activation. Such mechanisms fail
when more than 20% of muscle is lost due to trauma or chronic disease or surgery. The current
standard approach for treating volumetric muscle loss involves either tissue debridement or
muscle transposition [6]. Both procedures present a host of issues such as donor site morbidity
and incomplete recovery of pre-injury muscle strength and functionality [2]. Regenerative
engineering is a novel, alternative approach using the convergence of advanced materials
science, stem cell research, physical sciences, and areas of developmental biology and clinical
translation that has the potential to address muscle loss in moderate injuries with minimal to no
scar formation and may also offer a regeneration strategy in the case of large volume muscle
loss.
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In this chapter, cell therapy treatment for muscle repair and regeneration, and the benefits of
employing different types of biomaterials will be discussed. Also, the paper explores the
incorporation of small molecules and drug release concepts for muscle regeneration strategies
and discusses the impact of physical forces such as mechanical and electrical stimulation on
regeneration. Translational studies involving volumetric muscle loss model and rotator cuff
muscle injury will be discussed. These studies examine the potential of regenerative engineering
strategies to result in clinically meaningful results.
1.2 Cell Therapy
Muscular dystrophies are genetic myopathies, characterized by progressive muscle wasting and
degeneration. The most common and severe form is Duchenne muscular dystrophy (DMD),
which is caused by mutations in the dystrophin gene. Dystrophin is a structural component of
myocytes and is responsible for maintenance of muscle fiber integrity, mediation of cytoplasmic
signaling cascades and muscle functions [7]. The lack of functional dystrophin causes fragility of
muscle fibers during contraction. Damaged fibers may be repaired by proliferation and fusion
with activated proliferating satellite cells called myoblasts. However, the repaired fibers still lack
dystrophin leaving them vulnerable to injury through successive contractions. This progressive
and continuous faulty loop of degeneration and repair causes the myoblasts to rapidly senescence
[8]. DMD patients lose mobility between 10 and 12 years of age and die from respiratory and
cardiac failure by the third decade of life [9]. Unfortunately, there is still no cure for DMD. Cell
therapy approaches for degenerative muscle diseases have received significant attention for
treating these conditions. The cells used for transplantation can either be genetically corrected
autologous cells from the patient or allogeneic cells from healthy donors [7].
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1.2.1 Satellite cells/Myoblasts
Myoblasts were the first candidate cell types that were considered to treat muscular dystrophies.
Myoblasts are satellite cell-derived progenitors with the ability to generate skeletal muscle.
Studies performed in mdx mice (the most widely used animal model for DMD), demonstrated
that intramuscular injection of myoblasts resulted in their fusion with host cells to form new or
hybrid fibers, thus restoring dystrophin expression [10]. These encouraging results led to some
clinical trials in the 1990s, however, failed to show significant clinical benefit. The major factors
contributing to this unfavorable outcome were poor cell survival, limited cell migration and
immune rejection of the transplanted cells, which drastically reduced their engraftment [11].
Over the years, numerous studies have addressed these challenges and worked towards
overcoming them. A recent phase I/IIa clinical trial found that local injection of autologous
myoblasts in the pharyngeal muscles of patients with oculopharyngeal muscular dystrophy
(OPMD) is safe and efficient [12]. Myoblast cell therapy could be an effective treatment for
localized and less extended muscular dystrophies.
1.2.2 Muscle-derived stem cells (MDSCs)
Several other cell populations, other than satellite cells/myoblasts, from the muscle, were
subsequently investigated. Muscle-derived stem cells are postnatal stem cells identified and
distinguished from satellite cells by their relatively low level of commitment to the myogenic
lineage [13,14]. These cells are isolated from the skeletal muscle by the preplate technique, which
enriches the population of slowly adhering MDSCs by eliminating the populations of more
adherent cell types [15]. These cells offer several advantages over myoblasts such as high
proliferative and self-renewal capability, multipotency, and immune-privileged behavior resulting
in an overall improved transplantation efficacy compared to myoblasts/satellite cells [14,16].
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Notably, a population of poorly adherent MDSCs (known as MuStem cells) has been shown to
contribute to myofiber regeneration, satellite cell replenishment, and long-term dystrophin
expression in golden retriever muscular dystrophy dogs (the clinically relevant large model of
DMD). When systemically injected, these cells contributed to partial remodeling of the skeletal
muscle and enhanced regeneration resulting in a persistent stabilization of the dog's clinical status
and major improvement in locomotion features [17,18]. There have been reports identifying the
human analog of these muscle-derived cells [19,20]. However further studies will be needed before
they can be evaluated for their therapeutic potential.
1.2.3 CD133+ cells
CD133 is a transmembrane protein expressed on a subpopulation of circulating human
hematopoietic/endothelial progenitors. Torrente et al. showed that a subpopulation of CD133+
circulating cells expresses early myogenic markers. When injected systemically or intramuscularly
in scid/mdx mice, they were found to contribute to muscle regeneration, replenishment of the
satellite cell pool, and recovery of force [21]. Furthermore, their local injection appears to
accelerate skeletal muscle regeneration through increased vasculogenesis [22]. CD133+ cells have
also been isolated from human skeletal muscle. When injected intramuscularly in immunodeficient
mice, these cells were more efficient in regenerating skeletal muscle than human myoblasts mainly
due to their greater migratory potential and contribution to the satellite cell pool [23]. Also, a
double-blinded phase I clinical trial assessing the safety of autologous transplantation of human
muscle-derived CD133+ stem cells in DMD patients found no local or systemic side effects [24].
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1.2.4 Mesoangioblasts
Mesoangioblasts are vessel-associated stem cells that can differentiate into several mesoderm
cell types including skeletal muscle [25]. In inflammatory conditions, such as in DMD, they have
been shown to cross the vessel wall and colonize dystrophic muscles. This makes them cell
candidates to be delivered systemically. Intra-arterial delivery of murine and canine
mesoangioblasts has been shown to produce morphological and functional improvements in
models of muscular dystrophy [26–29]. The human equivalent of mesoangioblasts expresses
markers of pericytes, a subpopulation of muscle-resident cells. Human mesoangioblasts have
also been shown to cross the vessel wall and participate in muscle regeneration in dystrophic
muscles, restoring dystrophin expression [30]. Genetically corrected mesoangioblasts/pericytes
isolated from DMD models have shown to produce dystrophin-positive muscle fibers in vivo
[30,31]. Based on these pre-clinical studies, a phase I/II clinical trial for intra-arterial delivery of
HLA-identical allogeneic mesoangioblasts to patients with DMD under immunosuppression was
performed. The study proved to be relatively safe; however, minimal efficacy was observed, and
the outcome was inconclusive regarding muscle function. Further studies are needed to
determine the clinical benefit of mesoangioblasts for DMD patients [32].
1.2.5 Mesenchymal Stem Cells (MSCs)
Mesenchymal stem cells isolated from several sources such as the bone marrow [33–38], synovial
membrane [39,40], umbilical cord [41], and adipose tissue [42–46] have been identified for their
myogenic potential.
Adipose-derived stem cells (ADSCs) offer several advantages for cell therapy. They can be readily
isolated from an accessible adipose tissue source with little patient discomfort or donor site
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morbidity and expanded in large quantities [47]. Along with their multipotent differentiation
capacity [48], immunomodulatory properties, and anti-inflammatory and paracrine effects [49],
ADSCs are considered as one of the most promising and progressing stem cell populations for
tissue regeneration. Rodriguez et al. were the first to report on the use of multipotent adiposederived stem cells (hMADs) for skeletal muscle regeneration in vivo. When injected into mdx mice,
hMADs were able to restore dystrophin expression but failed to form myotubes [42]. Their
myogenic potential can be improved by forced expression of MyoD. However, the clinical safety
of lentiviral vectors has yet to be sufficiently proven [50]. Adipose tissue-derived cells have also
been shown to promote regeneration in other types of muscular disorders such as hind-limb
ischemia, limb-girdle muscle dystrophy (LGMD) or collagen VI-related muscle disorder
[43,45,46]. Furthermore, human adipose-derived stromal cells have been shown to migrate, engraft
and differentiate into muscle cells expressing dystrophin when administered intravenously into
GRMD dogs, without immunosuppression [44]. The immuno-privileged behavior of adipose
tissue-derived cells could be a significant clinical advantage for allogeneic cell therapy.
Overall, the ability of mesenchymal stem cells to contribute to muscle regeneration and improve
muscle function in vivo has not been conclusively established and requires further studies [34,36].
Nonetheless, because of their unique traits such as anti-inflammatory and immunomodulatory
properties [51], availability from various tissues, and trophic effects that indirectly have a positive
influence on repair and regeneration [52], MSCs are still being explored as candidates for muscle
cell therapy.
1.2.6 Embryonic stem (ES) cells and induced pluripotent (iPS) cells
Pluripotent ES cells can differentiate into cells of all three germ layers and generate large
numbers of specific cell populations, possibly overcoming the major obstacle of obtaining
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sufficient numbers of cells for cell therapy. There have been many studies focused on deriving
muscle precursor cells from ES cells that would be suitable for transplantation [53–57]; however,
given the ethical concerns surrounding the use of ES cells, attention has shifted towards using
iPS cells. Transplantation of patient-derived genetically corrected iPS cells offers the possibility
of autologous cell therapy, reducing concerns of immune rejection and donor availability.
Studies have reported successful generation of iPS-derived myogenic progenitors from patients
with genetic muscular diseases. These cells have shown the capability to contribute to skeletal
muscle regeneration upon transplantation [58–63]. Despite these promising results, safety and
efficacy issues still need to be adequately addressed before these cells can be used clinically.
1.2.7 Conclusion
The skeletal muscle is the largest organ in the body that is systemically affected by degenerative
muscular disorders. Therefore, a successful cell-based treatment would require systemically
delivering a large number of cells that are capable of targeting and migrating towards the needed
muscles. Studies so far indicate the potential of cell therapy for treating DMD. However
successful treatment would necessitate optimizing the in vitro expansion conditions, improving
the regenerative potential of cells and better understanding the role of the immune system and
immune response.
1.3 Conducting polymer
Conducting polymers (CPs) are a new generation of organic materials first produced in the mid1970s.
Research on CPs for biomedical applications expanded significantly in the 1980s when it was
found that conducting polymers were compatible with many biological molecules. Numerous
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applications are located such as neural probes,[64] neural prostheses [65][66]as well as controlled
release applications.[67][68][69][70] [71]. A primary conductive polymer such as polypyrrole
(PPy)[72][73] polyaniline (PANI) [74][72]polythiophene [75]and their derivatives[76][77][78][79]
was developed, and their biocompatibility in vitro and in vivo was studied.
More importantly, they have general properties that are desired for regenerative engineering
applications including conductivity, reversible oxidation, redox stability, biocompatibility,
hydrophobicity, three-dimensional geometry and surface topography[80][81].
Conductive polymers (CPs) can conduct charge because of the mobility of electrons within and
between polymer chains. The uniqueness is that they possess a conjugated backbone formed by
alternating single and double bonds, which makes particles easier to delocalize[82]. The crucial
part of the conductivity of CPs is doping[81][83]. It is well known that before doping, CPs are
generally insulative. Doping can result in a highly conductive polymer. The doping process is
influenced by factors such as polaron length, chain length, charge transfer to adjacent molecules
and conjugation length. For detailed mechanism, please refer to Bredas and Silbey’s book[84].
In one study done by Hsiao et al., aligned composite nanofibers of polyaniline (PANI) and poly
(lactic-co-glycolic acid) (PLGA) were doped by HCl so that electrospun fibers could be
transformed into a conductive form carrying positive charges, which could then attract negatively
charged adhesive proteins such as fibronectin and laminin, promoting cell adhesion[85].
Additionally, attempts have been made to incorporate biologically active dopants, which have
shown great promise in modifying conducting polymer-based materials[82]. For example, by
synthesizing conducting polymers PPy onto the porous PES membrane using heparin as both
ligand and dopant, a heparin-doped affinity membrane was developed. Adsorption capacity and
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rate of thrombin on affinity electromembranes are significantly facilitated by electrical stimulation
[77].
1.3.1 Polypyrrole (PPy)
There are several conducting polymers widely used in the biomedical engineering field.
Polypyrrole (PPy) is by far the most studied conductive polymer. Today it has numerous
applications in drug delivery, nerve regeneration, biosensor, as well as coatings for the neural
probe, nerve guidance channel [86][87][88][89][70][90][91]. Below is the figure of the
polypyrrole chemical structure. PPy possesses many attractive features that make it a promising
candidate to study in the regenerative engineering field. First of all, it is stimulus responsive so
that dynamic control of its properties is achieved by applying various electrical potentials[87].
More importantly, it has excellent in vitro and in vivo biocompatibility, excellent chemical stability
and reasonably high conductivity under physiological conditions[92][93][94]. PPy has ease of
synthesis in large scale with a wide range of solvents including water. It can also be fabricated in
large surface areas with desired porosities. To make it applicable in biomedical applications, the
incorporation of bioactive molecules has been used[95][64][96].

Figure 1.Chemical structure of polypyrrole 77
However, it is difficult to further process PPy once it is synthesized, since the high degree of
conjugation in the molecular backbone of PPy makes it very rigid, insoluble and poorly
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processable. Therefore, one way to compensate for the shortcomings is to use it together with
another polymer, combining the advantage of both materials. [97] [98] To give it flexibility, PPy
has been deposited onto polyester and polyethylene terephthalate (PET) fabrics. [99][100]
Composite structure has also been widely used. For example, PPy was used with PDLLA either
deposited on its surface to make a film [94]or into its matrix as nanoparticles. Nanocellulose–PPy
composites have also been created which exhibits excellent mechanical strength, flexibility, and
durability while possessing high conductivity, high capacity, and a fast ion exchange speed[86].
For bone tissue engineering applications, in a study done by Sajesh et al. a Chitosan/ Polypyrrole–
alginate matrix was developed. MG-63 cells were loaded, and it was found that PPy based matrices
supported cell attachment and proliferation. In vitro mineralization of the matrix suggested the
bioactivity of the matrix and apatite layer formation. Based on these results, it was recommended
that the matrix could be employed for bone tissue engineering using osteogenic cells. Also, by
combining electrical stimulation with a bioreactor system, further evaluation of the role of
conducting substrates in bone regeneration can be studied[101].
For PPy with and without electrical stimulation, the Shimit group investigated electrospun matrices
involving deposition of PPy on electrospun PLGA fibers. The PPy PLGA displayed electrical
activity and nanofibrous features. In vitro cell culture using PC12 cells and embryonic
hippocampal neurons demonstrated compatible cellular interactions, and that the fabricated PPy–
PLGA meshes are appropriate for neuronal applications and present topographies for modulating
cellular interactions comparable to the PLGA control nanofibers. Finally, electrical stimulation of
PC12 cells on the conducting nanofiber matrices improved neurite outgrowth compared to nonstimulated cells. Besides, further increases in neurite length and percentage of neurite-bearing cells
were observed with electrical stimulation on aligned conducting nanofibers. Studies have also
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shown that electrical stimulation of polypyrrole(PPy) increases the adsorption of fibronectin(FN)
from homogeneous FN solutions, as well as from serum correspondingly. These studies suggest
that increased FN adsorption with direct electrical stimulation may explain enhanced neurite
extension on electrically stimulated PP[102][103][89]. So far, PPy has been reported to support
cell adhesion and growth of many different cell types[104][103].
Furthermore, other efforts have been made to improve the biocompatibility of PPy through
modification, one example of this, as mentioned earlier, is the incorporation of bioactive
molecules[95][64][96]. An amino acid peptide, T59, was bound to PPy and provided novel means
of surface modification that does not reduce the bulk conductivity[105].
In another study, heparin was covalently immobilized onto electrically conductive polypyrrole
(PPy) film through poly (ethylene glycol) methacrylate (PEGMA) graft copolymerization and
subsequent cyanuric chloride activation. The PEGMA-graft-copolymerized PPy surfaces, with
immobilized heparin, had good bioactivity, indicated by a low level of protein adsorption, a high
ratio of albumin to fibrinogen adsorption, and low thrombus formation and the PPy film retained
significant electrical conductivity after surface modification[95].
1.3.2 Polyaniline
Besides polypyrrole(PPy), polyaniline (PANI) has also been studied widely due to its attractive
advantages such as ease of synthesis, tunable conductivity, environmental stability, and
biocompatibility[86].
PANI exists in various forms based on its oxidation level: the fully oxidized pernigraniline base,
half-oxidized emeraldine base, and sufficiently reduced leucoemeraldine base[83][86].
PANI can be synthesized by either chemical or electrochemical methods[106]. The advantage of
an electrochemical method is that the production of a PANI film is uniform, of high purity, and
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can be deposited and collected on a metal electrode[107]. However, more commonly, it is
synthesized by chemical methods, by oxidative polymerization of aniline in aqueous media in the
presence of an oxidizing agent. Other methods include but are not limited to emulsion, dispersion,
solution, interfacial, metathesis and self-assembling[108].

Figure 2.Chemical structure of polyaniline(PANI)77
PANI in its pure form demonstrates good biocompatibility both in vitro and in vivo and has been
combined with a variety of biodegradable polymers to form composites having specific
mechanical, electrical, and surface properties. [106] For example, electrically conductive
composite of poly (l-lactide-co-ɛ-caprolactone) (PLCL) blended with polyaniline (PANI) was
made using an electrospinning method. C2C12 myoblast was seeded on those matrices. The
results showed an increase in myotube number, length, and area with increasing PANI content.
This indicates that electrically conductive substrates can modulate the induction of myoblasts into
myotube formation even without additional electrical stimulation[109]. In another study,
electrospun fibers were made using PANI doped with camphorsulfonic acid (CPSA) and blended
with PLCL. The cell adhesion tests showed higher adhesion on CPSA-PAni/PLCL nanofibers than
pure PLCL nanofibers using human dermal fibroblasts, NIH-3T3 fibroblasts, and C2C12. More
importantly, the growth of NIH-3T3 fibroblasts is enhanced under the stimulation of various direct
current flows[110].

12

More efforts have been made to improve compatibility of PANi by either blending PANI with
other biocompatible polymers, such as PCL and gelatin mentioned above or by immobilizing cell
adhesive peptide sequences onto the PANI backbone. For example, in a study by Li and colleagues,
the bioactive peptide sequences Tyr-Ile-Gly-Ser-Arg (YIGSR), and Arg-Tyr-Ser-Gly-Ile (RYSGI)
were grafted onto PANI backbones, and the resulting cellular behavior and biocompatibility were
compared with unmodified PANI. The result showed higher cell adhesion amount, and the grafting
of adhesive peptides also improved proliferation of neuronal PC-12 cells. [111][106]
No table of figures entries found. In recent years, Poly (3,4-ethylenedioxythiophene) (PEDOT)
captured a considerable amount of attention driven by the advances of biotechnology. Compared
to polythiophene, PEDOT has a dioxyalkylene bridging group across the 3- and 4-positions of its
heterocyclic ring (Figure 3) greatly improving its properties by lowering its band gap, reduction,
and oxidation potential[112]. This is also what grants PEDOT its good electrical, chemical and
environmental stability as well as better conductivity and thermal stability than PPy[112]. So far,
It is considered the most successful polythiophene derivative, with so many interesting
properties[113].
1.3.3 Poly(3,4-ethylenedioxythiophene) (PEDOT)

Figure 3.Chemical structure of (a) Polythiophene. (b) Poly(3,4-ethylenedioxythiophene)77
Biocompatibility of this polymer has been studied. For example, in one study, epithelial cells were
cultured on a PEDOT surface. The results showed that epithelial cells, Hep-2, present significant
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activity on the surface of poly(3,4-ethylenedioxythiophene) electrodeposited on stainless steel
electrodes and there is no sign of cytotoxicity[113].
In another study by Luo et al., NIH3T3 cells were seeded on synthesized PEDOT films, and
biocompatibility was assessed. An in vivo study was done by subcutaneous implantation of
PEDOT films. The results showed that PEDOT films exhibit very low intrinsic cytotoxicity and
that their inflammatory response upon implantation was excellent, making them promising for
biosensing and bioengineering applications[79].
PEDOT has also been chemically polymerized within acellular muscle tissue, where it formed a
network of elongated tubular structures throughout the tissue due to the chemical and thermal
stability of the PEDOT polymer depositions, it could be of great use for applications in peripheral
nerve repairs as well as in biosynthetic prostheses [112].

Figure 4.Optical micrographs of mouse abdominal acellular muscle tissue (AMT) samples.
Top row is images taken from 3-mm transverse sections; bottom row is images taken from 2-mm
longitudinal sections, all at 40 magnification. In both rows, from left to right: (A) and (B) sonicated
control AMT constructs; (C) and (D) sonicated AMTþ poly(3,4-ethylenedioxythiophene construct
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subjected to 1 cycle of polymerization (PEDOT1) constructs, and (E) and (F) sonicated
AMTþPEDOT6 constructs.[112]
PEDOT has also been applied to neural electrodes. In one study, a neural electrode was interfaced
with the surrounding brain tissue through the in situ polymerization of PEDOT. This formed
PEDOT filaments are extending far enough away from the electrode to breach the glial scar around
it and forming sensitive contacts with the plasma membrane of the neurons[114].
When used in the drug release applications, PEDOT coated electrospun nanotubes were
incorporated with dexamethasone. It was reported that the drugs could be released from the
nanotubes in a controlled fashion by electrical stimulation of the nanotubes [68].
In Martin’s group, a dual-component cochlear implant coating was also developed to improve both
the electrical function of the implant and the biological stability of the inner ear. This coating
combines an arginine-glycine-aspartic acid (RGD)-functionalized alginate hydrogel with poly(3,
4- PEDOT). Both in vitro and in vivo assays on the effects of these electrode coatings demonstrated
improvements in device performance. This coating is non-cytotoxic, clinically relevant, and has
the potential to improve the cochlear implant user's experience[67] significantly.
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1.4. Surface modification of tissue grafts
There are both challenges and high demands for workable and straightforward surface
modification in the biomedical research area. Inspired by the composition of adhesive proteins in
mussels, Lee's group reported a simple and direct method to form multifunctional polymer coatings
through simple dip-coating of objects in an aqueous solution of dopamine.[115] Dopamine selfpolymerization was able to build thin, surface-adherent polydopamine films onto a wide range of
both inorganic and organic materials, such as noble metals, oxides, polymers, semiconductors, and
ceramics. Secondary reactions can be used to create a variety of ad-layers, including selfassembled monolayers through deposition of long-chain molecular building blocks, metal films by
electroless metallization, and bioinert and bioactive surfaces via grafting of macromolecules.[115]

Figure 5. Photograph of a mussel attached to commercial PTFE
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(B and C) Schematic illustrations of the interfacial location of Mefp-5 and a simplified molecular
representation of appropriate amine and catechol groups. (D)The amino acid sequence ofMefp-5
(13, 34). (E)Dopamine contains both amine and catechol functional groups found in Mefp-5 and
were used as a molecular building block for polymer coatings. (F)A schematic illustration of thin
film deposition of polydopamine by dip-coating an object in an alkaline dopamine solution.
(G)Thickness evolution of polydopamine coating on Si as measured by AFM of patterned
surfaces.[115]
Such chemistry has been widely used in the tissue engineering field. For example, Tsai et al.
reported poly(dopamine) deposition onto electrospun poly(ε-carprolactone) PCL to significantly
promoted rat osteoblasts adhesion and proliferation. Mineralization was also increased on the
poly(dopamine)-deposited surfaces[116]. This indicated that there is much potential of
poly(dopamine) deposition in the tissue engineering field.
1.5 Growth factors and small molecules in Skeletal Muscle Regenerative Engineering
A common strategy in musculoskeletal regenerative engineering is the delivery of bioactive factors
to stimulate the development of engineered tissue [117]. These signaling molecules can be
incorporated within biomaterial-based matrix systems to enhance the proliferation and
differentiation of stem cells and progenitor cells. Based on the properties of each factor and
molecule, different encapsulation techniques may be used to modulate the release profile and
maximize their desired therapeutic effect [118]. Two standard approaches are physical
encapsulation, where the molecules are embedded within the biomaterial matrix during the matrix
fabrication process, and chemical immobilization, where the bioactive factors are adsorbed or
covalently bonded onto the surface of the structure [119,120].
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In skeletal muscle regeneration, signaling molecules play an essential role in guiding the
differentiation and proliferation of satellite cells into myoblasts, and eventually to multinucleated
myofibers [121]. Growth factors are signaling proteins that through interaction with specific
binding receptors, activate signal transduction pathways[119,122]. Major growth factors present
throughout the skeletal muscle regeneration process include hepatocyte growth factor (HGF),
insulin-like growth factor (IGF), fibroblast growth factor (FGF), transforming growth factor-b
(TGF-b), and vascular endothelial growth factor (VEGF) [123–125]. (Fig. 1) illustrates the
contribution of these growth factors during each stage of muscle regeneration [123].
Studies have shown the capability of incorporating growth factors within engineered skeletal
muscle constructs to enhance regeneration both in vitro and in vivo. TGF-b1 plays a vital role in
myogenesis through regulating satellite cell proliferation and differentiation, as well as promoting
endothelial cell activity [125,126]. Weist et al. investigated the effect of TGF-b1 in improving the
functionality of 3D skeletal muscle constructs. The muscle construct was derived from an adult rat
tail tendon seeded with satellite cells [127]. At a TGF-b1 concentration of 2.0 ng/mL, a significant
increase in the differentiation, contractility, and extracellular matrix deposition by the cells was
observed. Studies have also shown that HGF and FGF-2 signaling play an important role in
stimulating satellite cell activation and proliferation, and when delivered in unison, the therapeutic
effects are significantly improved [128–130]. Hill et al. were able to develop an HGF and FGF-2
dual delivery system using G4RGDSP peptide modified alginate polymer matrices to study their
effects on myoblast migration and survival in vitro [131]. HGF and FGF-2 (250 ng) were added to
the alginate solutions and subsequently gelled to form the matrix. The percent viability and
migration of the myoblasts at day five within the peptide-modified matrices were significantly
higher than the control and the HGF/FGF-2 separate groups. Similarly, VEGF has been studied as
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a potential factor to stimulate neoangiogenesis and vascularization.[132,133] Analogous to HGF,
IGF-1 can be utilized to trigger satellite cell differentiation and proliferation through the PI3K/Akt
and Ras/Raf-1/ERK MAP kinase signaling pathways [134,135]. Borselli et al. explored the
synergetic capability of delivering VEGF and IGF-1 to promote the repair of injured muscle within
the ischemic hindlimbs of mice [136]. The mice were injected with 50 µL of alginate gel containing
three µg of VEGF and IGF-1 either alone or in combination. Subsequent data analysis illustrated
that the sustained delivery of both growth factors restored the functionality of the skeletal muscle,
with a reduction in ischemia.
In spite of pre-clinical and clinical success with growth factor-mediated regeneration, certain
limitations

still

exist.

These

include

their

high

production

cost,

immunogenicity,

supraphysiological dosage requirement, high market cost, and instability during the drug delivery
formulation process [137,138]. The capability of harnessing the therapeutic potential of small
molecules for musculoskeletal regenerative engineering applications, therefore, has raised
interest[122]. Small molecules are organic compounds with a molecular weight of less than 1000
Da. They can rapidly diffuse through the cellular membrane and regulate specific biological
processes [139]. The inherent properties of these small molecules have resulted in improved
stability, low production cost, and lower levels of immunogenic response compared to their growth
factor counterparts [140,141]. However, due to the potential of non-specific side effects, the route
of administration and dosage amount must be taken into account to maximize their
pharmacological effect.
Several small molecules have gained a significant level of interest within the realm of skeletal
muscle regeneration. Sphingosine 1-phosphate (S1P) is a sphingolipid biomolecule responsible for
the modulation of several functions in muscle progenitor cells varying from the differentiation of
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myoblasts to the motility and division of satellite cells [142,143]. Danieli-Betto et al. studied the
in vivo activity of S1P in skeletal muscle repair through injecting a 50 µM concentration of S1P
into the damaged soleus muscle of rats and mice [144]. A significant increase in the cross-sectional
area of the myofibers and the expression of MyoD and myogenin were observed in the treated
muscle tissues [145]. Retinoic acid (RA), a derivative of vitamin A, was studied to understand
their ability to differentiate stem cells into a myogenic lineage. Kennedy et al. treated P19 and
mouse embryonic stem cells with RA. [146,147] Significant increase in the expression of MyoD,
myogenin, Meox1, and Pax3 was observed in the treated embryonic stem cells, implying the
potential of RA as a therapeutic option in skeletal muscle regeneration. Lee et al. used a
combination approach to screen the skeletal muscle regeneration potential of a range of small
molecules [148,149]. Two small molecules, skeletal muscle inducer 1 and 2 (SMI 1 and 2), has
been identified due to their ability to enhance Pax3 expression through the upregulation of the Wnt
and suppression of the Shh and Smad 2/3 signaling pathways.
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Figure 6. Schematic representation of the growth factor contributes to the three stages of muscle
regeneration. Adapted from Ref 69 with permission from Elsevier
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1.6 Biomaterial strategy for skeletal muscle regeneration
A biomaterial-based strategy has progressed tremendously over the past few decades. An ultimate
biomaterial needs to be biocompatible, biocompatible, has appropriate mechanical stability, longterm in vivo functionality as well as to provide a conductive structure for cellular proliferation and
differentiation[150][2].
A combination of both biomaterials and cells can potentially improve the therapeutic effects of
cells for muscle regeneration[2].
1.6.1 Electrospun nanofiber matrices
It is highly desirable to engineer matrices that mimic the natural extracellular matrix.
Electrospun nanofibrous matrices are beneficial because of their similarity to natural muscle
fibers[151]. For example, Choi et al. used aligned co-electrospun poly(e-caprolactone) PCL and
collagen nanofibers to evaluate its potential for skeletal muscle regeneration. The study showed
the ability of matrices to support alignment and myotube formation of skeletal muscle cells
(hSkMCs), implying its potential substrate to treat patients with large muscle losses[152]. This
was further demonstrated by Aviss et al. using aligned PLGA nanofiber matrices seeded with
C2C12 murine myoblasts. The myoblasts not only showed aligned morphology but also had a
significantly higher expression of muscle differentiation markers such as fast myosin heavy
chain compared with randomly oriented fibers[153]. In addition to substrate alignment, electrical
cues have also shown to promote myotube formation. Electrically conductive random and align
matrices were prepared by adding different weight percentage of polyaniline (PANI) into poly
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(ε-caprolactone) (PCL). The study showed that substrate alignment along with electrical
stimulation could favorably affect skeletal muscle regeneration[154][109].
1.6.2 Hydrogels
Hydrogels are prepared from both natural and synthetic polymers with high water content[155].
They have been extensively used in biomedical field[67][156].
Rossi et al. used in situ photo-cross-linkable hyaluronan-based hydrogel to deliver satellite
cells(SCs) or muscle progenitor cells (MPCs to treat partially ablated tibialis anterior (TA) mice.
It showed a significant improvement when the injured tibialis was treated with freshly isolated
satellite cells encapsulated in a hydrogel. Alginates cannot specifically interact with mammalian
cells. Rowley et al. studied the effect of hydrogel chemistry. Used alginates from different
monomeric ratio to covalently bond with RGD-containing cell adhesion ligands. The study showed
a significant impact of alginate monomeric rate or the density of RGD ligands attached at the
surface of a substrate on myoblast proliferation and differentiation[150].
Using alginate matrix, Borselli et al. showed that transplanted myoblasts combined with localized
delivery of VEGF and IGF-1 could enhance muscle regeneration and angiogenesis[157]. Nichol
et al. demonstrated that gelatin methacrylate (GelMA) was useful in creating cell-responsive
microtissues, such as endothelialized microvasculature[158]. The hydration and mechanical
properties of GelMA can be tuned via degree and polymer concentration so it will be suitable based
on different applications[158]. Another study investigated the role biomaterial can play in
providing skeletal muscle with mechanical competence matrix. The matrix was prepared by using
different protein type (collagen I/fibrin/Matrigel) encapsulated in neonatal rat skeletal muscle cells
to form bundles. The result ended in an increase in contractile force derived mainly from cell-
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matrix interactions. In summary, the biomaterial can play a crucial role in modulating cellular
response for effective skeletal muscle regeneration[159][160].
1.6.3 Patterned matrices
In addition to types of material, cell behavior can also be altered via substrate surface
features[161]. Patterning is a favorite technique to modify biomaterial surface properties. It
generally involves the use of an elastomeric master such as PDMS, which is easy to mold or
emboss and can be used directly as a substrate for biomedical applications [5]. A unique study
by Yang et al. has shown that muscle-derived cells cultured on gelatin-coated nanopatterned
PLGA substrates showed enhanced myogenic contribution in vivo compared to cells grown on
flat PLGA after four weeks of transplantation[162]. The group further demonstrated that by
combining electrical and topographical cues, nanopatterned electroconductive substrates created
by capillary force lithography could mimic highly aligned collagen bundles from the
extracellular matrix of skeletal muscle tissue. The combination of both topographical and
electrical cues can enhance myogenic differentiation and maturation[163]. A unique study has
shown, when they cultured muscle-derived cells on gelatin-coated nanopatterned PLGA
substrates and transplanted into quadriceps muscles of mdx mice, those nanopatterned cell
patches enhanced myogenic contribution in vivo compared to patches generated from flat PLGA
after four weeks of transplantation[162]. Besides that, many groups have found other influencing
factors such as groove depth or width of imprinted submicron and different surface materials,
such as polystyrene[164], agarose[165] as well as methacrylate gelatin[166]. For example, Yang
et al. used electron beam deposition (FIG.2) to achieve a thin layer of either gold or titanium on
nanopatterned substrates to create electroconductive substrates with thin layers of either gold or
alumina. It is found that biomimetic nanotopography combined with these coatings promotes
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myogenic differentiation and maturation[163]. Together, they all play an essential role in the
formation of functional myotubes in vitro[167],[168].

Figure 7. A schematic illustration of the fabrication of A) unpatterned and patterned PUA
substrates and B) electron beam evaporation deposition of Au and Ti onto PUA substrates111.
Adapted from Ref [163] with permission from Elsevier.
1.6.4 Decellularized tissues
Biologic matrices that are composed of extracellular matrix (ECM) have been used to both
reinforce or replace damaged tissues in clinical applications[169]. Decellularized tissues can
maintain their ECM structure as well as their vascular network and have mechanical properties
resembling native tissue[2].In a study done by Wolf et al., decellularized skeletal muscle ECM
matrix was shown to provide bioactive compounds such as growth factors, glycosaminoglycans,
and basement membrane structural proteins that are typically missing from non-muscle ECM
derived from the small intestine (SIS). The decellularized skeletal muscle ECM has shown to
support myogenic cells proliferation in vitro. In vivo implantation in a rat abdominal wall injury
model showed constructive remodeling response along with matrix degradation, even though it
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showed no statistical difference in remodeling outcome compared with SIS induced ECM[170].
Another study by Ward et al. tested the hypothesis that functional muscle efficacy can be retained
by using a lesser amount of autologous muscle grafts can be volumetrically expanded by using a
collagen hydrogel. The study showed that even approximately around 50% of the minced graft
(but not 75%) suspended in a collagen hydrogel, muscle functionality is similar to those of the
100% minced graft repair. More studies are required to identify optimal carrier materials for
expansion efficient regeneration[171].
Valentin et al. tested four types of grafts, porcine small intestinal submucosa (SIS)-ECM,
carbodiimide-crosslinked porcine SIS-ECM, autologous tissue as well as polypropylene mesh in
the rat injury model. The graft (1.5 cm × 1.5 cm) is placed on the defect in the ventral lateral
abdominal wall musculature (Fig.3). Among the four matrices, both biologic matrices composed
of non-crosslinked SIS and an autologous tissue graft supported functional skeletal muscle
reconstruction. The regenerated tissue didn’t mimic native tissue but abundant vascularization and
innervation along with the presence of types I and II muscle fibers in this regenerated muscle[169].
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Figure 8. Representative image of tissue flap
Top: the musculoskeletal defect was created by excising the external and internal oblique layers
of the abdominal wall, leaving the transversal fascia intact. Middle: the test article was implanted
in the defect site and secured with Prolene sutures at each of the four corners. Bottom: twenty-six
weeks post-implantation, a flap of tissue was created which contained the site of test article
placement, identified by the preplaced Prolene sutures. The tissue flap maintained the integrity of
the muscular arteries and the thoracic spinal nerve branches that supplied the site of tissue
remodeling. The dense connective tissue at the insertion site at the linea alba was connected to the
force transducer with silk suture and positioned such that the direction of the contractile function
testing was aligned parallel to the rib origin. Platinum electrodes were placed across the flap
proximal and distal to the matrix placement site[169]. Adapted from Ref [169] with permission
from Elsevier.
The creation of very first tissue-engineered muscle repair (TEMR) construct showed a significant
improvement in enhancing myotube numbers as well as functional improvement by two months
of implantation in a murine latissimus dorsi (LD) muscle with a surgically created VML
injury[172][173]. In short, acellular bladder matrix (BAM) was used as a matrix to culture muscle-
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derived cells (MDSc) for ten days allowing for cell growth and differentiation in media, and then
preconditioned in a bioreactor with a 10% uniaxial mechanical as described[172]. Subsequently,
another study investigated the role of preconditioning MDSc with the uniaxial mechanical strain
on decellularized ECM with TEMR-positive responders. The study demonstrated combination
approach significantly increase functional recovery in skeletal muscle compared with construct
alone in VML injury. The study demonstrated the potentially greater regenerative capacity of
therapies that include the stem or progenitor cells in addition to a matrix[174].
1.6.5 Electrically conductive materials
Electrically conductive biomaterials are considered as one of the most promising new
generations of materials that can provide direct delivery of electrical, electrochemical or
electromechanical stimulation from a substrate to cells[86][175].W ith the development of
biocompatible electrically conducting materials, several biomedical applications have been
identified[175][176][71]. Polypyrrole (PPy)[177][89][101] polyaniline (PANI) 89[106],
polythiophene and their derivatives[112][178] have been tested in bone, neural or skin
regeneration. For example, Gilmore studied the potential benefits of modified polypyrrole on
skeletal muscle growth and differentiation. Briefly, polypyrrole was doped with significant
components of the extracellular matrix such as hyaluronic acid (HA) and chondroitin sulfate A
(CS) as well as non-biological active molecules such as a dodecyl benzene sulphonic acid
(DBS), and para-toluene sulphonic acid (pTS)). The doped polymers supported myoblast
differentiation and myofiber formation to some extent. Besides, different polymer dopant
differentially affected various stages in skeletal muscle myogenesis. It was found that physical
properties of the films such as PPy/ HA, PPy/pTS were better suited to facilitating different
stages in skeletal muscle myogenesis[104].
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As mentioned in 4.1, in another study, Jun and Chen et al. both showed improved myoblast
differentiation when cultured on PANI in combination with poly(L-lactide-co-ε-caprolactone)
(PLCL) electrospun fibers[154][109].The presence of conducting polymer PANI was found to
have a significantly increased myotube maturity as well as increased myogenic genes such as
myogenin, troponin T, and MHC[154][109].
Ahadian et al. incorporated different concentrations of multi-walled carbon nanotubes (MWNTs)
into gelatin fibers. It showed improved mechanical properties demonstrated by an increase in
Young's modulus in the presence of MWNTs from (509 ± 37 kPa to 1077 ± 266 kPa and 1170 ±
168 kPa for gelatin nanofibers containing 0 mg/ml, 0.5 mg/ml, and 5 mg/ml MWNTs),
respectively. Increased myotube formation and maturation were observed with increased matrix
stiffness due to increased mechanotransduction in these substrates[179]. Patel et al. used an acid
catalyzed sol-gel process to produce silica coating on the CNT-grafted hierarchical substrates.
The generated carbon nanotube (CNT) carpets were deposited on both interconnected
microporous carbon foams as well as aligned carbon fiber mats. The result showed that the foam
structure did not support myotube formation whereas, on aligned carbon mats, myocytes fuse
into multinucleated myotubes supporting hypothesis. This indicated that specific areas of the
nanostructure could provide surface roughness and wettability that can correctly facilitate
myoblast adhesion, growth and differentiation into myocytes[180].
1.7 External stimulation to enhance muscle regeneration
Biophysical stimulations such as mechanical and electrical forces play an essential role in
modulating muscle cell growth and differentiation[181][182].
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1.7.1 Mechanical stimulation of myoblast differentiation
Mechanical stimulation can potentially be an efficient approach for muscle regeneration[1].
Du et al. demonstrated the unique advantage of in vitro preconditioning protocol on primary
human muscle cell-matrix construct using appropriate mechanical force[183]. Those constructs
were subject to cyclic strain inside a computer-controlled bioreactor system. It was discovered
that those retrieved constructs generated tetanic and twitch contractile responses with a specific
force of 1% and 10%, unlike the native tissue constructs[183].
Vandenburgh et al. used a cell stimulator device to dynamically stretch embryonic skeletal
muscle cells where they maintain the cells in a horizontal position during mechanical stretching
of up to 400% in substratum length[184]. The study showed the following advantages such as 1.
The ability for myoblasts fuses into robust and abundant arrays of myotubes which are 2 to 4
times longer than those myotubes grown under static culture conditions. 2. There is an increase
in cell proliferation and better orientation because of prestretching the collagen-coated
substratum before cell plating[184].
This was further demonstrated by Cezar et al. using biphasic ferro gels capable of substantial,
fatigue-resistant deformations to treat a severe injury of C57BL6/J mouse anterior muscle. As
shown in fig 4 The biphasic ferro gel stimulated directly to the tissue when the pressure cuff
externally compresses muscle through the skin. The stimulation led to uniform cyclic
compressions of the flesh on the injured site. Importantly, because of its superior properties, it
was used to mechanically stimulate and regenerate a severally injured muscle construct without
the addition of cell therapies or growth factors. The study showed the feasibility of using a
biologic free matrix that could significantly enhance muscle regeneration[185].
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Figure 9. Biphasic ferrogels and pressure cuffs generate cyclic mechanical compressions.
(A) Experimental design showing injury, implant, and stimulation profile. (B) Schematic of
biphasic ferrogel implant in mouse hind limb depicting the orientation of ferrogel relative to the
skin, muscle tissue, and magnet (Left). Pressure profile of biphasic ferrogel undergoing repeated
magnetic stimulations (Right). (C) Schematic of pressure cuff on mouse hind limb depicting the
orientation of balloon and polycarbonate cuff relative to skin and muscle tissue (Left). Pressure
profile of balloon cuff undergoing repeated inflations and deflations (Right). Adapted from Ref
[185] with permission from Elsevier. Ultrasound has also been used as a physical force to
enhance skeletal muscle regeneration[186]. The EPI® technique is an ultrasound-guided
technique that can generate a galvanic current transmitted through an acupuncture needle,
localized lysis towards degenerated tissue[186]. Abet et al. used EPI technique to treat tendon
muscle lesions in a rat model and observed a significant increase in anti-inflammatory proteins
(PPAR-γ) as well as VEGF and VEGF-R1 expression. Therefore, it enhances the treatment of
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muscle injuries[1].All in all, these studies indicate the potential advantages of mechanical
stimulation to enhance muscle regeneration.
1.7.2 Electrical stimulation of myoblast differentiation
In vivo, electrical signal play an essential role in the development, function, and repair of tissue
and organ [187–189]. Various groups, therefore, investigated electrical stimulation as an
alternative approach to enhance cellular functions [189]. Overall the ability to improve myotube
formation and maturity has been demonstrated upon electrical stimulation [190,191].
Nedachi et al. demonstrated robust, evident contraction activities of C2C12 when they were
subjected to electrical stimulation (40 V/60 mm, 2 ms, 1 Hz) [190]. The study showed the
efficacy of electrical stimulation on cells to produce contraction-inducible myokines have could
favorably modulate metabolic, immune responses and angiogenesis (ES) [191]. Also, other
studies also reported the ability of electrical stimulation to support muscle cells elongation and
secretion of bioactive factors such as insulin growth factor-1, in skeletal muscle cells [192,193].
Langelaan et al. compared the efficacy of C2C12 cell with primary cell culture under electrical
stimulation through utilizing a collagen type I/Matrigel™ hydrogel. Under electrical stimulation,
both 2D and 3D culture witnessed accelerated sarcomere assembly formation. Also, primary cell
source was preferred as they were more susceptible to the electrical stimulus [194].
Pedrotty et al. evaluated the effect of electrical current flux on the mitogenic activity of skeletal
muscle-derived cells in vitro. The cells were seeded on 3-D polyglycolic acid mesh scaffolds and
were subjected to cardiac-like electrical current fluxes treatment, or using culture condition
media obtained from mature cardiomyocytes. The study showed that both electrical stimulation
and cardiac-derived soluble factors could stimulate cell proliferation [195].
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Burch et al. compared gene expression in electrically stimulated muscle cell culture with nonelectrically simulated muscle cells. The electrically stimulated C2C12 mouse muscle cells
showed qualitative transcriptional adaptations similar to those in trained muscle, but muscle gene
expression differed from those with acute effects of exercise. It will be useful for the study of the
molecular mechanisms that regulate exercise adaptation in muscle [196]. Furthermore, Trumble
et al. have shown that long-term stimulation of rabbit muscle could change muscle fiber types
and remodel extracellular matrix indicated by the presence of collagen type I and fibrillin [197].
Besides, the ability of chronic low-frequency stimulation to induce the formation of slow muscle
fibers and enhance glucose uptake in skeletal muscle has also been demonstrated [178,198].
1.8 Volumetric Muscle Loss(VML)
Although skeletal muscle has its intrinsic ability to regenerate, massive defects such as
volumetric muscle loss (VML) cannot be regenerated[199].
In a cohort of battlefield-injured soldiers, muscle conditions were found to take up more than
65% of the disability. Furthermore, 92% of the muscle conditions were identified as VML,
addressing this means a significant change in orthopedic care12[200].
The current standard approach for volumetric muscle loss is to use functional free muscle
transfer and advanced bracing[201]. Although it looks promising, the procedure is very
complicated and successful outcome of the surgery depends on the surgical team. Moreover, the
results of usage of free muscle transfer may not be viable in patients with combat extremity
injuries[201]. Advances in the use of tissue engineering matrices and stem cells suggest a
promising solution. It is exciting to imagine that a biomaterial matrix that can be surgically
implanted at the site of VML, encouraging local muscle regeneration and improving function in
both animals and humans[202].
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People have been exploring matrices utilized in different animals models[199]. Tissue
engineering strategies discussed in the last chapter that use different types of matrices with or
without stem or progenitor cell source are under development for the treatment of trauma such as
volumetric muscle loss [203]. Developing an appropriate animal model to test these approaches
is also important.
To mimic volumetric muscle loss, in animal surgeries, the creation of a VML is achieved using
aseptic technique. In a murine model, The VML injury model was created by surgically
removing around 50% of the lattissimus dorsi (LD) muscle area in anesthetized nu/nu mice[172].
Briefly, after a longitudinal incision along the midline of the back, trapezius muscle that covers
the LD muscle was lifted. The medial half of the muscle was removed indicated by suture
markers using a scissor[172]. In a rat model, defect dimension ten mm*7mm* 3mm were first
labeled and removed using a scalpel from the medial and lateral margins of the muscle[204]. In
general, a surgical defect was created in the middle third of the TA muscle and a significant
portion of the estimated TA muscle weight will be removed[202–205].
Corona et al. used three different bladders acellular matrix (BAM) collagen matrices seeded with
muscle-derived cells (MDCs) section 4.2 to create TEMR construct in a mouse model. Based on
the histological and molecular results, those TEMR constructs helped promote muscle
regeneration at different rates and magnitudes. Functional recovery via regeneration of
functional muscle fibers occurred either at the interface of the construct and the native tissue or
within the BAM matrix independent of the native tissue[206].
Corona also evaluated the efficacy of syngeneic muscle-derived ECM (mECM) seeded with
bone marrow-derived mesenchymal stem cells in treating rat tibialis anterior (TA) muscle VML
injury. The study showed the feasibility to recover one-third of the first functional deficit two
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months post-surgery using mECMs. Moreover, the presence of mECM decreased further muscle
damage in the remaining muscle sees (Fig.5)[203]. The study pointed out that with the help of
these new biological ECM matrices, prolonged overload of injury muscle is prevented in this
case[203].

Figure 10. The contribution of donor-derived myogenic cells to de novo fiber regeneration after
VML injury. TA muscle minced grafts derived from donor GFP-Lewis rats were transplanted to
the site of VML injury at a 100% tissue replacement.
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(A) Longitudinal (scale bar = 1.0 cm) and (B–E) cross-sections (scale bars = 50 lm) from the
remaining muscle mass (B, C) and defect area (D, E) were probed for sarcomeric myosin and
GFP co-localization. TA, tibialis anterior; VML, volumetric muscle loss[171].
There are also other research groups suggesting such that SIS-ECM may not be effective in
promoting muscle regeneration[207] This may be related to differences in matrix fabrication
process as well as a selection of surgical models. (TA muscle vs. lateral gastrocnemius
employed)[208]. Adapted from Ref [208] with permission from Elsevier.
The efficacy of ECM based matrix to treat VML injury was demonstrated by Badylak et al. using
a canine model. The study showed that an ECM-based matrix helped promote functional
restoration of the distal gastrocnemius musculotendinous junction after complete resection of the
tissue[207].
In another study with canine injury models, the study was carried out using non-crosslinked
ECM derived from porcine small intestinal submucosa(SIS). Although the initial modeling
process showed promising results at later stages showed fibrosis, dense collagenous tissue and a
small portion of nonfunctional muscle in a complex quadriceps muscle injury in dogs
models[208]. Further study is required to understand the efficacy of these biological matrices in
treating VML[208].
So far, ECM matrices have been on the preclinical trial. Sicari et al. evaluated ECM matrices
using a mouse VML model and showed the ability of the matrix in supporting skeletal muscle
formation as well as innervation. This was followed by a clinical study using this matrix in five
patients with VML. Six months post-ECM all patients showed signs of new muscle formation
and blood implantation at the site of implantation. Three of the five patients showed 20% or
more significant improvement in limb strength during physical therapy. The two patients without
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functional changes did report improvements in nonfunctional tasks, such as balance, as well as
an increase in the quality of life. Because of the widespread availability and known safety of
cell-free ECM-based materials, they hold promise as a candidate material in treating VML[202].
1.9 Muscle atrophy in rotator cuff injury
Rotator cuff tear is one of the most frequently seen orthopedic conditions, and repair of rotator
cuff tears is a common procedure[209]. As the rotator cuff ages, it becomes nonresistant to
degenerative tears. It was estimated that 40% of those aged over 60 are bothered with rotator cuff
issues, and repair failure rate ranging from 20% to 70% remains a significant clinical
challenge[210].
Tears that are higher than 4 cm are called large RCTs. They have been found to cause atrophy as
well as fatty infiltration in supraspinatus and infraspinatus muscle[211]. In Cofield's study,
roughly 94% of patients with large RCT experienced atrophy and fatty infiltration and resulted in
a relatively poorer recovery outcome in comparison with those that do not have atrophy and fatty
infiltration. The poor issues of large tears are due to the inelasticity and reduced function of the
muscle-tendon unit and can lead to shoulder dysfunction [212][213]. Upon rotator cuff tear, the
study showed an increase in symptoms and tore size over time[213].
Gladstone et al. demonstrated poorer skeletal muscle quality, especially in the region of
infraspinatus, negatively affects the outcome. Also, it has been shown a successful rotator repair
can significantly decrease the likelihood of fatty infiltration and muscle atrophy[214].
All in all, chronic RCTs can lead to pain and suffer the patients, poor shoulder function,
pain[211]. So far current studies have been having been focused on developing improved repair
techniques[215], using biologic factors[216] or biomaterials[217][218] to enhance tendon to
bone healing. Repair with aligned PCL electrospun matrix augmentation was compared with
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control with no matrices. The results showed that with implantation of matrices, there is better
cellular infiltration. No adverse effect of surgical implantation was observed[219]. Thangarajah
et al. used demineralized bone matrix (DBM) derived from cortical bone to treat female Wistar
rats with three weeks' delayed repair. The study result showed a shorter gap between tendon and
bone. Less disorganized structure and less abnormal collagen fiber were observed compared with
commercially available GraftJacket. However, the use of DBM matrices didn't show
improvement of enthesis healing compared with nonaugmented controls or GraftJacket [218].
Zheng et al. used 3D aligned collagen/silk matrix (ACS) to treat rabbit tendon tear. Both
improvements of better cellular infiltration and enhanced tenogenic differentiation were
observed[220].
There are no current biomaterial strategies addressing muscle atrophy issue in rotator cuff injury,
but the condition exists. Research-wise, people have been using animal models such as rats,
rabbits or sheep to determine the temporal changes that take place in the region of supraspinatus
muscle after tendon detachment[221][220]. It was hypothesized that tendon detachment would
lead to lack of load thus would cause significant muscle weight loss as well as a conversion of
the muscle types. Using a rat rotator cuff model Barton et al. observed a consistent fiber shift
throughout the study, rapid loss of muscle volume as well as scar tissue formation in the muscle
bed[222].
In a study done in a rat rotator cuff model by Davis et al. regarding to both acute and chronic
rotator cuff repair, they stated that at the time of chronically torn rotator cuff repair, failure to
successful repair the tendon will lead to continuous progression of fatty degeneration, which is
commonly seen in some patients that received rotator cuff repair[223].
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Rowshan et al. used a rabbit denervation rotator cuff injury model and found that it will worsen
muscle atrophy and fatty degeneration. Six weeks after injury, muscular changes in the complete
tear group or with the nerve transection group had similar but significant decreases in wet mass
and increases in fat content relative to the control groups[224].
In larger animal models, signs of muscle atrophy and fatty infiltration after injury are more
visible. Luan et al. using a sheep rotator cuff model also demonstrate the occurrence of muscle
atrophy and fatty infiltration six months after initial surgery. The repair group still had increased
expression of muscle atrophy, fatty infiltration, and fibrosis-related genes. The study
demonstrates the clinical importance of addressing fatty infiltration and fibrosis upon rotator cuff
tear[225].
1.10 Concluding remarks
In this review, we first discussed cell-based strategies which are conventional but very useful to
this day. Then we talked the use of small molecules and drugs in muscle regenerative
engineering. Since biomaterials play an increasingly significant role in regenerative muscle
tissue engineering, detailed discussions were given on different types of materials, how materials
interact with cells and how they modulate physical, chemical or mechanical behaviors of cells
that can alternate cellular activities. It is evident that the potentials of biomaterials are not only
vehicles that deliver cells, drugs or small molecules, but also at as tools that control cellular
functions, therefore enhancing the endogenous muscle regeneration response. It was also
discovered that muscle contractility and functionality could be improved by physical forces such
as mechanical and electrical stimulation. Furthermore, this article has been focusing on the
translational side of biomaterials. Many research groups have been started testing their
biomaterials on animal's models or even in clinical trial. It is fascinating as the ultimate goal is to
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transfer all these biomaterials "from bench to bedside." To do this, a deeper understanding and
discoveries need to made in advanced materials science, stem cell area, physical forces,
developmental biology, and clinical translation. It is not unusual nowadays to see material
scientists, clinicians as well as biologists working together to make biomaterials and cell
therapies translational.
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CHAPTER 2. PRELIMINARY STUDIES AND SPECIFIC AIMS
2.1 Preliminary Results

Figure 11.Schematic illustration of the conducting polymer coated matrices228
The substrate material was electrospun using optimized parameters of 15 % (w/v) PCL solution
in ethanol and methylene chloride (15:85 ratio) with a 2.5 mL/min flow rate, and 1 kV/cm-1
potential at ambient temperature and humidity to obtain bead-free nanofibers.
Conductive matrix fabrication:
2mg/ml dopamine was applied to the surface for 24 hours at pH 8.5 to polymerize onto the
surface of PCL fiber mats to form a polydopamine coating2. The modified DOPA-PCL surfaces
were washed, dried, and subsequently coated with 1% PEDOT: PSS, 10% PEDOT: PSS, 33%
PEDOT: PSS, and 100% PEDOT: PSS solution, where the 100% solution indicates a PEDOT:
PSS 1.3wt% dispersion in H2O and 33%, 10%, 1% are further diluted with PBS. The dried
matrices were treated with mild acetic acid pH 2 to enhance its conductivity[226].

(a)
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(b)

Figure 12. XPS analysis on (a) Dopamine polymerized PCL matrices. (b) PEDOT: PSS coated
dopamine polymerized PCL matrices
Fig. 2(a). It shows that dopamine treatment was successful by the presence of nitrogen on the
surface of the composite nanofibers as confirmed by XPS, where the N 1s peak was observed at
399.872 eV for the dopamine polymerized PCL matrices. According to the literature, there was
no nitrogen peak being found in the PCL samples[154,227]. (b) Both sulfer in PSS and sulfer in
PEDOT were shown. The percentage are 52% against 48%, which indicated that acid treatment
did take away excessive PSS[226], as the original PEDOT:PSS ratio was 1:2.5. XPS analysis
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confirmed that poly(dopamine) eposition on the PCL matrices was successful,which was
consistent with previous reported literature[228]. The additon of PEDOT:PSS was stable as both
representative peaks were shown. Besides, acid treamtent took away excessive PSS as the final
PEDOT:PSS ratio was almost 1:1 compared to intial 1:2.5. We have successfully coated
PEDOT:PSS onto surface modified PCL matrix. This matrix fabrication method was
straightforward yet effecitve. It provided an alternative approach as coducting polymers are
conventionally electrochemically deposited on hard surfaces and the fabrication process invovled
several steps[64,229].

Figure 13.Day 1 C2C12 cells live dead (100% indicates 100%PEDOT: PSS, 33% indicates 33%
PEDOT: PSS etc)

After seeding 80K C2C12 myoblasts on each treatment group of the nanofiber matrices, cell
viability was qualitatively assessed using a Live/Dead Cell Viability assay kit. As shown in (Fig.
3), between the six groups, after 1 day, the vast majority of the cells were viable, suggesting that
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the developed matrices were cytocompatible and can provide topographical cues to for cell
growth.

Figure 14.C2C12 cells three-day proliferation study
80K C2C12 cells were seeded on matrices on each of the 6 test groups. From the proliferation
study on day 3 on (Fig. 4), Statistically, PEDOT:PSS of high concentration groups (33% and 100%)
showed similar effect on cell viability compared to the control group. Interestingly, PEDOT:PSS
of a low and medium concentration(1% and 10%) showed stimulatory effect on C2C12 growth
compared to the control groups as there was statistically significance between these groups. This
results showed that the presence of PEDOT:PSS at optimun concentration may enhance C2C12
cell growth. It confirmed our hypothesis that conducting polymers may have a positive effect on
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cell growth, proliferation or even differentiation,which needs more investigation. This platform
may further be optimized for tissue engineering or bioelectric applications when combined with
small molecules, growth factors and along with electrical stimulation.

2.2 Overall Objective and Specific Aims
Around 40% to 45% of the human body’s mass consists of skeletal muscle. Remarkably, skeletal
muscle has the ability to perform robust self-repair after injury[230][2]. However, when a large
volume of muscle is lost as a result of trauma or due to chronic disease, the ability of skeletal
muscle to regenerate is limited[202]. The current therapeutic approach for muscle volumetric
loss is to transfer and engraft healthy, vascularized, and innervated autologous tissue. Yet, this
approach does not lead to full recovery of pre-injury muscle strength and functionality, and
harvesting skeletal muscle can cause donor site morbidity[2]. Here we propose to use
regenerative engineering as an alternative approach for patients with large volume muscle loss to
prevent scar tissue formation and for restoration of muscle function in moderate injuries[2]. A
more clinically viable matrix would satisfy the following attributes: biocompatibility, mechanical
stability, long term in vivo functionality (electrical conductivity), complete cell residence
throughout the three-dimensional structure, as well as cues to support and promote the
proliferation and differentiation of cells throughout the three dimensional structure of the matrix.
Our goal in this study is to modulate the cellular physical microenvironments to allow the
application of controlled electrical impulses via electroconductive nanofiber matrices to generate
a more robust and functional muscle construct for muscle regeneration. The development of this
system may have a significant clinical impact, where muscle atrophy and fatty infiltration
prevent healing of rotator cuff injuries[213]. In order to determine the success of these methods
the research has been organized into the following specific aims:
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2.2.1 Specific Aim 1
Specific Aim 1: Evaluate the utility of electroconductive nanofiber matrices with tunable
conductivity.
Nanofiber matrices will be fabricated by incorporating a conducting polymer,
poly(3,4ethylenedioxythiophene): poly(styrenesulfonate) (PEDOT:PSS), onto the surface
modified electrospun nanofiber metrics. Electrospinning of random and aligned fibers will be
made. It is hypothesized that the created polymer is biocompatible, electroconductive, and
mechanically competent. Scanning Electron Microscopy (SEM) will be used for characterization
of fiber diameter and orientation. Dopamine polymerization will be applied onto poly(εcarprolactone) PCL surface. The surface chemistry will be tested using XPS. Different
concentrations of PEDOT: PSS solution will then be coated onto the poly(ε-carprolactone) PCL
nanofibrous matrices. Biocompatibility of matrices coated with different concentration of
PEDOT: PSS will be studied using a cell viability assay as well as live/dead staining. The
physicochemical and biological properties of the matrix will be optimized and used for specific
aim 2.
Challenges, Pitfalls, and Alternative Strategies: From the preliminary results, we do not
anticipate issues in fabricating the matrix with appropriate physicochemical and biological
properties. However, maintaining the efficient electrical conductivity of the matrix throughout
surgery may be challenging due to matrix degradation and complex biological processes. As an
alternative, we propose either to make coelectrospinning of conducting polymer with PCL
matrices, or we can plasma treat the PCL matrices to make them more hydrophilic and
susceptible to coating of a conducting polymer thereby providing long-term electrical
conductivity.
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2.2.2 Specific Aim 2
Specific Aim 2a: Determining the effect of topographical cues to enhance myoblast
differentiation of C2C12, a myoblast cell line, and mouse muscle stem cells (satellite cells) in
vitro.
It is hypothesized that aligned electrospun nanofibers could provide surface functionality by
mimicking parallel alignment of the multinucleated fibers of muscle tissue. PCL matrices with
random orientation and aligned orientation will be compared and evaluated. Phenotypic
progression will be assessed through RT-PCR (Real-Time Quantitative Reverse Transcription
PCR) to see if there is upregulation of myogenic regulatory factors. Myotube formation will be
assessed through immunohistochemistry, cells will be stained for sarcomere-myosin heavy chain
(green) and nuclei(blue). It is expected that compared to random orientation matrices, the aligned
matrices will facilitate differentiation of C2C12 cells. Studies will be carried out first in C2C12,
a myoblast cell line, and then in mouse muscle stem cells (satellite cells).
Challenges, Pitfalls, and Alternative Strategies: Based on preliminary cell proliferation study,
cell number was higher on aligned electrospun nanofiber matrices than random electrospun
nanofiber matrices at day 7. However, pure PCL electrospun nanofibers may be hydrophobic
which would decrease cell attachment and proliferation. As an alternative, we propose to
compare the effect of topographical cues on dopamine modified electrospun nanofibers, which
are hydrophilic and support cell growth and differentiation.
Specific Aim 2b: Evaluate the ability of electroconductive matrices to promote migration,
proliferation, and differentiation of both C2C12, a myoblast cell line, and mouse muscle stem
cells (satellite cells) in vitro.
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In addition to specific aim 2a, it is hypothesized that the addition of electrical cues will enhance
cell proliferation and myogenic differentiation. Myogenic differentiation will be assessed
through RT-PCR and immunohistochemistry. Matrices with random orientation and aligned
orientation coated with conducting polymer will be compared and evaluated. It is expected that
conducting polymer-coated matrices will facilitate myoblast differentiation compared to control
matrices. Studies will be carried out first in C2C12, a myoblast cell line, and then in mouse
muscle stem cells (satellite cells). Based on these experiments, the optimized matrix that yields
the best overall in vitro performance will be selected for Specific Aim 3.
Challenges, Pitfalls, and Alternative Strategies: From the preliminary study an upregulation of
gene expression of C2C12 cells on electroconductive matrices was seen. However, if the
conducting polymer, with its intrinsic conductivity is not efficient to stimulate muscle
differentiation, as an alternative we propose to add an electrical field to the cells. It is known that
electrical signals can modulate cell growth and differentiation by guiding remodeling of the
cellular microenvironment and by regulating gene expression[231]. Electrically excitable
C2C12 muscle cells will be seeded in electrically conductive matrices and stimulated with pulsed
voltage and frequency[231].
2.2.3 Specific Aim 3
Specific Aim 3: Evaluate the biological performance of the optimized novel electroconductive
matrices in a clinically relevant, well-established rat rotator cuff defect model.
It is discovered that massive rotator cuff tears have close association with atrophy, fibrosis, and
fatty infiltration (FI) of the supraspinatus and infraspinatus muscles. Thus it is hypothesized that
electroconductive matrices seeded with satellite cells will improve functional tendon and muscle
regeneration[213]. It is also hypothesized that delivery of skeletal muscle satellite cells from the
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electroconductive matrices will significantly improve tissue regeneration via recruiting
circulating stem cells, and in turn increase/modify ECM protein synthesis and
immunomodulation.
Skeletal muscle satellite cells will be isolated from male rats and seeded on aligned PCL
electrospun nanofiber substrates as well as PEDOT: PSS coated aligned electrospun nanofiber
substrates. The aforementioned tissue engineered constructs will then be transplanted to the
tendon insertion site following an existing protocol. In brief, the subscapularis tendon will be
exposed through an incision under the clavicle. Spreading of the deltopectoral interval to expose
the shoulder and coracobrachialis muscle will allow exposure of the subscapularis tendon. Full
thickness tears of the tendon will be made by complete transection of the subscapularis tendon
from the bone[232]. To assess engraftment, rats will be euthanized and tissues will be harvested
at certain time point post-transplantation for analysis. Tendon tissue sections will be imaged and
quantified using immunohistochemistry. Histology of tissue will also be looked at as an evidence
of fatty infiltration or regression[232][233].
Challenges, Pitfalls, and Alternative Strategies:
There is an established rat rotator cuff model. The PI is a renowned orthopedic surgeon and is
extensively published in this area. Additionally, personnel who are trained in the surgical
technique will conduct the surgery, therefore we do not anticipate any problems with surgical
reconstruction. However, the mechanical characterization of the bone-tendon interface may be
challenging. As an alternative, we propose to characterize the bone-tendon interface
histologically.
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CHAPTER 3: EVALUATE THE UTILITY OF
ELECTROCONDUCTIVE NANOFIBER MATRICES WITH
TUNABLE CONDUCTIVITY

3.1 Introduction
Conducting polymers (CPs) are a novel generation of organic materials first produced in the mid1970s[71]. Research on CPs for biomedical applications expanded greatly in the 1980s when it
was found that conducting polymers were compatible with many biological molecules.
Numerous applications are found such as neural probes,[64] neural prostheses [65][66]as well as
controlled release applications.[67][68][69][70][71].Major conductive polymer such as
polypyrrole (PPy)[72][73] polyaniline (PANi) [74][72]polythiophene [75]and their
derivatives[76][77][78][79] were developed and their biocompatibility in vitro and in vivo were
studied. More importantly, they have general properties that are desired for regenerative
engineering applications including conductivity, reversible oxidation, redox stability,
biocompatibility, hydrophobicity, three-dimensional geometry and surface topography[80][81].
Here in this chapter, I am charactering Poly(3,4-ethylenedioxythiophene) (PEDOT), a
polythiophene (PTh) derivative, newly emerged in recent decades. It has already being used in
numerous biomedical applications such as biosensing and bioengineering applications [234],
electrical controlled drug release[68], as well as nerve grafts and heart muscle patches[112], it
will be used in this study for muscle cell and material interface regeneration. It has captured a
considerable amount of attention owing to its good electrical, chemical and environmental
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stability and better conductivity and thermal stability than conventionally studied
polypyrrole(PPy)[86].
3.2 Materials and Methods
PCL, dopamine hydrochloride (average Mw 8000), and poly (3,4-ethylenedioxythiophene)polystyrene sulfonate (PEDOT: PSS 1:2.5) were purchased from Sigma-Aldrich.
3.2.1 Matrix preparation
In this study, substrate material of random strucutre was electrospun using optimized
electrospinning parameters of 15 % (w/v) PCL solution in ethanol and methylene chloride (15:85
ratio) with a 2.5 mL/min flow rate, and 1 kV/cm-1 potential at ambient temperature and humidity
to obtain bead-free nanofibers. Substrate material of aligned strucute was electrospun using a
rotating motor setup and was optimized at 6V to produce aligned strucutre. Dopamine (2mg/ml)
was applied to the surface for 24 hours at pH 8.5 to polymerize onto the surface of the PCL fiber
mats and form a polydopamine coating[115]. The modified DOPA-PCL surfaces were washed,
dried, and subsequently coated with 30 µl of 1% PEDOT: PSS, 10% PEDOT: PSS, 33%
PEDOT: PSS, or 100% PEDOT: PSS solution, where the 100% solution indicates a PEDOT:
PSS 1.3wt% dispersion in H2O and 33%, 10%, 1% are further diluted with PBS. The dried
matrices were treated with mild 13.3% acetic acid, which is pH 2 to enhance its conductivity.
3.2.2 Characterization of conductive matrices
The fiber morphology and diameter of all groups were examined by scanning electron
microscopy (SEM) (FEI Nova NanoSEM 450). Briefly, the fibers were mounted onto sample
studs and coated with gold using a sputter (Polaron E5100) for 3 minutes. The SEM images were
analyzed with ImageJ software to determine the average fiber diameter. The average and
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standard deviation of the fiber diameter were calculated from 50 random measurements per
image.
3.2.3 Conductivity testing
The conductivity of the different concentrations of conductive matrices (1 inch × 1 inch, n=3)
was measured using the four-point probe technique using a Keithley 6000 picoammeter
(Keithley; Cleveland, Ohio) at a voltage sweep of 1–10 V by applying a constant current of 2.5
mA between two alligator clips. The conductivity (σ , S cm −1 ) of the electroconductive
substrates ( n = 3) was calculated based on the equation: σ = l / (R s S) (where l is the distance
between reference electrodes, R s is the bulk resistance of the membrane sample derived from an
impedance analyzer, and S is the cross-sectional area of the sample) as previously reported[235].
3.2.4 Surface Wettability Analysis
The water contact angles of substrates were measured to examine surface wettability in relation
to topography and surface coating. The surface hydrophobicity of various matrices was
determined by adding a droplet of deionized water (5 µL) onto a dry sample at room temperature
and allowing the droplet to equilibrate for 10 s. The water droplet images were captured by a
charge-coupled device (CCD) camera, and the mean contact angles were then calculated using
ImageJ software analysis (National Institutes of Health, Bethesda, MD). The surface
hydrophobicity of the blend films was determined by measurement of the contact angle of water
using a contact angle and surface tension meter (KSV Instruments Ltd). The contact angle of
each sample was taken as the average of three measurements at different points on the surface of
the samples.
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3.2.5 Statistical Analysis
All quantitative data were expressed as the mean ± standard deviation. Both one way and twoway ANOVA tests were used. The Tukey pairwise comparison test was performed on samples
to determine significant differences. The assumptions for ANOVA were found to satisfy
Levine’s test for homogeneity of variance and passed tests for normality. A value of p < 0.05
was considered statistically significant.
3.3 Results
3.3.1 Conducting polymer particle size distribution

Figure 15. Particle size distribution

We used PEDOT:PSS 1.3wt% dispersion in H2O (Sigma Aldrich). For proper
particle size distribution, 1:30 dilution was made to original solution. It showd an average size
of 384.9 ± 3.8 nm.
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3.3.2 Electroconductive nanofiber matrices illustration

Figure 16.Schematic illustration of the conducting polymer coated matrices and myotube
formation on those electroactive matrices.

First, we electrospun the substrate material using optimized electrospinning parameters of 15 %
(w/v) PCL solution in ethanol and methylene chloride (15:85 ratio) with a 2.5 mL/min flow rate,
and 1 kV/cm-1 potential at ambient temperature and humidity to obtain bead-free nanofibers.
Then, we used dopamine to polymerize on the surface of the PCL matrices for 24 hours at a pH
of 8.5. The modified DOPA-PCL surfaces were washed, dried, and subsequently coated with
different concentrations of PEDOT: PSS. The dried matrices were treated with mild acid to
enhance its conductivity [226].
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In the experiment conducted in this report, pure PCL serves as control 1, while dopamine
(DOPA) coated PCL serves as control 2. 1% means DOPA -PCL matrices were coated with 1%
PEDOT:PSS , 10% with 10% PEDOT:PSS, 33% with 33% PEDOT:PSS, and 100% with 100%
PEDOT:PSS. (Note: 100% means use as purchased which is PEDOT:PSS 1.3wt% dispersion in
H2O. 33%, 10%, 1% are further diluted with PBS solution.)
3.3.3 SEM analysis
PCL

DOPA

33%

10%

100%

Figure 17. SEM showing nanotopography preservation and PEDOT distribution (8000x)

From the SEM images in (Figure 2), the topography of pure PCL nanofiber metrics shows a
smooth surface while dopamine polymerized surface shows some surface roughness without a
change in its diameter. The distribution of PEDOT:PSS is relatively uniform. There is an
increase in PEDOT:PSS particles as the concentration of solution increases. The differences of
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topographies and confuctivity may affect myoblast morphology and maturation, which will later
be discussed further.
3.3.4 Contact angle measurement

(a) Pure PCL

(b) Dopamine polymerized PCL

Figure 18. Contact angle analysis for (a) Pure PCL (b) Dopamine polymerized PCL
Contact angle shows 125.3 0C from untreated PCL to 0 0C of dopamine polymerized matrices.
From the result, we can know that the dopamine coating is effective in changing hydrophobicity
while minimize changing fiber morphology (fiber diameter unchanged from SEM analysis).
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3.3.5 Conductivity measurement

Figure 19. Sheet Resistance of different concentration of PEDOT:PSS coating
Electrical properties of PEDOT:PSS coated matrices have been studied by repeating sheet
resistance measurements with a four point probe method.[236]
Sheet resistance is inversely propotional to condutivity. We observed changes in surface
electrical conductivity with respect to the different concentraions of conducting polymer (Figure
3), which is consistent with SEM images in Figure 2. Pure PCL matrices or dopamine coated
PCL matrices have no detectable electrical conductivity. DOPA-PCL coated with different
concentrations of PEDOT:PSS demonstrated a wide range of electrical conductivity, with the
100% group possessing average sheet resistance values of around 5× 104 , 33% around 13× 105,
and 10% around 17× 106. The 1% group showed relatively higher and inconsistent resistivity,
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and thus is not listed on the figure. From the sheet resistivity testing, it can be concluded that
conductivity is directly correlated to PEDOT:PSS solution concentration.
3.3.6 In vitro evaluation of electroconductive nanofiber matrices
In vitro C2C12 cell adhesion and proliferation on electroconductive nanofiber matrices

Figure 20. C2C12 Proliferation on PEDOT Coated PCL Nanofibers
80K C2C12 cells were seeded on matrices on 6 test groups (consistent with live dead study).
From the proliferation study on day 3, day 7 and day 14, no toxicity was shown among all
treatment and control groups. PEDOT of higher concentration (33% and 100%) inhibited cell
proliferation in the first week, then started showing a stimulatory effect on C2C12 growth in
second week. PEDOT of a low and medium concentration(1% and 10%) showed stimulatory
effect on C2C12 growth during first week and second week. In general, it is observed that
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PEDOT of low and medium concentration (1% and 10%) promoted a higher level of cell
growth than the two control groups.
3.3.7 Live dead staining on C2C12 cells
100%

33%

10%

1%

DOPA

PCL

Figure 21. Live dead on PEDOT Coated PCL Nanofibers Day 3
80K C2C12 cells were seeded on matrices on 6 test groups. On day 3, 3 representive images
were taken for each group and live dead cells were counted. All six groups showed more than
90% cell viablity, which indicates mild or even no cytotoxicty. For the 1% and 10% group, the
cell density is similar to the two control groups and are relatively higher than the 100% and 33%
groups. This suggests that high concentraions of PEDOT:PSS may have an impact on cell
proliferation but exhibits very mild toxicity.
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3.4 Discussion
The demand for alternatives approach to currently available muscle flaps has inspired
regenerative tissue enginnering field with many carefully designed matrices[2]. Here in this
chaper, the design goal is to create a conductive matrices with minimun but effcient conductivity.
The ultimate goal is to modulate the cellular physical microenvironments to allow the application
of controlled electric impulses via electroconductive nanofiber matrices to generate a more
robust and functional muscle construct for muscle regeneration.
Dopamine polymerzation in preliminary data section suggested that this type of method is
successful. Acid treatment can take away excess PSS thus enhanceing sheet conductivity. It aslo
changed surface hydrophlicity from 120 °𝐶 to 0 °𝐶. Dilution of original conducting polymer
showed uniform partcile size based on particle size distribution graph. SEM images showed that
higher concentration, more roughness in the surface of nanofibers but it won’t change nanofiber
surface diameter. Electroconductive nanofiber matrices with tunable conductivity were
successfully fabricated. Four-point probe conductivity testing substantiated that the conductivity
could be controlled by modifying the concentration of PEDOT:PSS applied on matrices. The
100% group possessed an average sheet resistance value of ~5× 104, while the conductivities of
the 33% and 10% group were 13× 105 and 17× 106, respectively. The preliminary assessment of
biocompatibility of the C2C12 cells seeded on the matrix was performed using live/dead assay
and cell titer blue assay. It has been shown that the presence of PEDOT: PSS in the matrices
enhanced the muscle cell viability, attachment and proliferation. Analyzing all the experimental
data from different types of matrices, we concluded that the incorporation of conducting polymer
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might facilitate muscle cell growth. The results of in vitro cell viability assays suggested that
PEDOT:PSS coating exhibited no toxicity.
Further studies will examine the ability of the this conductive matrices in vitro in regards to its
proliferation and differtiation properties. All these findings in conjunction with those here will
assist in the development of an optimized conductive matrix for muscle tissue engineering.
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Chapter 4. EVALUATE THE ABLILITY Of
ELECTROCONDUCITVE MATRICES TO PROMOTE
MIGRATION, PROLIFERATION, AND DIFFERTIATION IN
VITRO
4.1 Introduction
As previously mentioned, a current standard approaches for muscle volumetric loss is to transfer
and engraft healthy, vascularized, and innervated autologous tissue. However, it comes with a
host of morbidity issues and there is not total recovery to pre-injury muscle strength and
functionality[2]. The introduction of regenerative engineering methods can be a potential
treatment option for patients with a large volume muscle loss. Meanwhile, it is highly desired to
create a stimulus-responsive biomaterial with easy-to-tailor properties. For example, electrical
signals are critical physiological stimuli that can be used to control adhesion and differentiation
of cell types such as neuron and muscle cells[109]. Nowadays, the use of conducting polymers
has been more studied in the area of neuron regeneration, biosensors, neural implants, drug
delivery devices and regenerative engineering matrices[86]. A novel stimuli-responsive
conducting polymer matrix was already engineered and successfully fabricated in last chapter. In
this chapter, we are going to assess muscle cell adhesion, proliferation and differentiation on this
matrices in vitro.
Our hypothesizes is that aligned electrospun nanofibers could provide surface functionality by
mimicking parallel alignment of the multinucleated fibers of muscle tissue. Further, it is
hypothesized that the addition of electrical cues will enhance cell proliferation and myogenic
differentiation.
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4.2 Material and Methods
4.2.1 Electrospinning of aligned matrices
10 mL of the PCL solution was placed into the syringe in the electrospinner with a 2.5 mL/min
flow rate, and 20KV at 15 cm distance at ambient temperature and humidity to obtain bead-free
nanofibers. A rotator was used to produce sheets with aligned nanofibers. After optimization, 6
V rotator voltage was chosen as optimum voltage for speed to produce consistent aligned
nanofibers. Fiber diameter ranges from 2um to 5um. It falls the same range as random nanofibers
fabricated previously.
4.2.2 Culture of murine skeletal muscle cells C2C12myoblasts(C2C12)
C2C12myoblasts (CRL-1772) (ATCC, Manassas, VA) were used to study cell proliferation and
differentiation on fibers. Cells were cultured in DMEM supplemented with 10% FBS and 1%
penicillin–streptomycin (p/s) under standard culture conditions (37 OC, 5% CO2). For cell
culture, circular matrices were punched out using 5’ size puncher, approximately 1.9 cm2 and
sterilized with 70% ethanol and UV for half an hour. Cells were seeded onto the different groups
at a density of 100K per well or matrix and cultured with growth media for 3 days. To induce
myotube formation, the media was then replaced with differentiation media (DMEM
supplemented with 2% horse serum and 1% p/s) and cultured for an additional 5 and 11 days.
4.2.3 Satellite muscle cell isolations
We followed a straight forward protocol for skeletal muscle satellite cells isolation using
FACS.[237]
It involves 31 steps on how to isolate and characterize satellite cells from mouse hindlimb
muscles.
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4.2.4 Live/dead cytotoxicity assay
Cytotoxicity of the 1% PEDOT: PSS, 10% PEDOT: PSS, 33% PEDOT:PSS, and 100%
PEDOT:PSS as well as dopamine polymerized PCL and pure PCL matrices were determined
with the live/dead cytotoxicity assay. CellTracker green and ethidium homodimer-1 (Molecular
Probes) were added to day three cultures of C2C12 cells on the above-described matrices to
determine cell viability (green fluorescence) and cell death (red fluorescence) through the use of
laser scanning confocal microscopy (Leica TCS SP2, Germany). The results represent the mean
values of three individual samples for each type of matrix.
4.2.5 Cell proliferation
For the cell proliferation studies, 80 K cells were seeded on each of the matrices. After 3, 7, and
14 days of cell culture, the cell proliferation was determined using a MTS assay kit (CellTiter
96® AQueous One solution, Promega) according to the manufacturers’ instructions Briefly,
assays were performed by adding a small amount of the CellTiter 96® AQueous One Solution
Reagent directly to culture wells at specific intervals, incubating for half an hour and then
recording the absorbance at 530nm/590 nm with a micro plate reader. The absorbance values
were normalized by the background readings. A standard curve of cell number that corresponds
to MTS activity were constructed for the specific C2C12 used in the current study.
4.2.6 Immunohistochemistry
Myotube formation was evaluated on cells fixed after 11 days of differentiation. The C2C12
cells cultured with differentiation media on pure PCL matrices and electrically conductive PCL
matrices were immunostained for sarcomeric-MHC and indicate myotube formation. The cells
were washed with PBS and fixed with 4% paraformaldehyde (Sigma-Aldrich, St Louis, MO,
USA) at room temperature for 15 min and then gently washed with PBS an additional two times.
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Cell membranes were then permeabilized with 0.1% Triton X-100 (Sigma-Aldrich, St Louis,
MO, USA) in PBS for 5 min. After rinsing three times with PBS, nonspecific binding sites were
blocked with 5% bovine serum albumin with protein blocker solution (Sigma-Aldrich, St Louis,
MO, USA) for 30 min at room temperature. Following this, the samples were sequentially
incubated with MF20 (1:200, Anti-MHC Alexa Fluor 488) over night at 4 °C. The stained
samples were mounted with Vectashield containing 4', 6-diamidino-2-phenylindole (DAPI;
Vector laboratories, Burlingame, CA) or Propidium Iodide (ThermoFisher Scientific) and
images were captured with confocal microscopy (Nikon A1 confocal).
4.2.7 Quantitative RT-PCR
The gene expression was evaluated via quantitative real-time polymerase chain reaction (qRTPCR) for the C2C12 cells cultured on different substrates after 6 days in differentiation medium,
according to the following procedure. Total RNA was extracted from the C2C12s cultured on
various substrates (n = 3) using the RNeasy Minikilt (Qiagen Sciences, Valencia, CA, USA).
After RNA extraction, cDNA was prepared from 1µg RNA using reverse transcription reagents.
Quantitative PCR was performed using Power SYBR Green PCR Master Mix. The expression
levels of relative myogenic differentiation genes (MyoD, MyoG, Tnnt1) were measured by
quantitative real time PCR (PCR system 7900HT). Quantification of target genes was performed
relative to the reference glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene, using the
following formula: relative expression = 2 [− (Ct sample – Ct GAPDH)] . The mean minimal
cycle threshold values (Ct) were calculated from quadruplicate reactions. Then, the relative gene
expression in each experimental group was normalized to the relative gene expression found in
the reference sample.
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4.2.8 ELISA analysis
After 14 days of culture, the 10% PEDOT: PSS group, dopamine, and PCL group, initially
seeded with C2C12 cells, were lysed using lysis buffer. The samples in lysing buffer were
centrifuged and assayed using an ELISA kit (TNNI1 elisa kit: Mouse troponin I type 1 (skeletal,
slow)) following the manufacturer instructions (myBiosource). The plates were read at 450 nm
using 540 nm as the reference wavelength based on the manufacture’s instruction and analyzed
using construction of a standard curve. The detection range of the kit is between 7.8 pg/ml-500
pg/ml. Total protein of each matrix was determined using a commercially available BCA protein
assay kit (Pierce, Rockford, IL, USA). The amount of TNNT1 on each matrix was also
normalized to the total protein amount.
4.2.9 Statistical Analysis
All quantitative data were expressed as the mean ± standard deviation. Both one way and twoway ANOVA tests were used. The Tukey pairwise comparison test was performed on samples
to determine significant differences. The assumptions for ANOVA were found to satisfy
Levine’s test for homogeneity of variance and passed tests for normality. A value of p < 0.05
was considered statistically significant.
4.3 Results
4.3.1 Cell morphology on matrices
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PCL

10%

DOPA

33%

1%

100%

Figure 22. SEM images of C2C12 cells on treatment groups after two hours of cell seeding.
Based on this SEM image, no clear trend of cell attachment was found, indicating PEDOT
coating did not affect short term cell attachment. (Here 100% means 100% PEDOT: PSS coated
matrices dopamine polymerized PCL matrices, 33% means 33% PEDOT:PSS coated matrices
dopamine polymerized PCL matrices, 10% means 10% PEDOT:PSS coated matrices dopamine
polymerized PCL matrices,1% means 1% PEDOT:PSS coated matrices dopamine polymerized
PCL matrices, DOPA means dopamine polymerized PCL matrices, PCL indicated PCL
electrospun nanofiber matrices)
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Figure 23. C2C12 Attachment on PEDOT Coated PCL Nanofibers (2h)
Again, we can see that with two hours of cells seeding, around 20 to 30 k cells were attached on
matrices. Although there is no significant difference between the groups, this could possibly due
to high variance of each of the groups.
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Figure 24.C2C12 Morphology on PEDOT Coated PCL Nanofibers-D3
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Figure 25. C2C12 Morphology on PEDOT Coated PCL Nanofibers-D7
During sample processing, some of the samples were by day 7, under low magnification and
high magnification, we can observe that cell patches were spread on electrospun nanofibers.
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Figure 26. C2C12 Morphology on PEDOT Coated PCL Nanofibers-D14
By day 14, all groups have shown to form patches of cell sheets here and there. The cells were
well spread following nanofiber structure.
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Figure 27.C2C12 Morphology on PEDOT Coated PCL Nanofibers-D21
C2C12 morphology showed the cells were well spread on matrices. By 21 days it is very
confluent. On all of the groups, cells were connected with each other and formed layers of
sheets. By this time, nanofiber feature is hardly seen but it has provided excellent platform for
cells to grow and proliferate. All in all, topographical cues may be provided for cells to grow and
differentiate.
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Figure 28. 100% PEDOT: PSS SEM morphology at D14
Based on this figure, it suggested that even 100% PEDOT: PSS can have C2C12 cells proliferate
on the matrices. Suggesting PEDOT: PSS is a biocompatible polymer.
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4.3.2 Cell viability on Matrices
100%

33%

10%

1%

DOPA

PCL

Figure 29. Cytotoxicity: Live dead staining

Live dead staining showed that there are more dead cells on higher concentration of PEDOT:
PSS but there is no obvious toxicity for all six groups.
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Figure 30. SEM image of C2C12 cells seeded on six matrices on day 3.

SEM images suggested that C2C12 morphology showed the cells were well spread on all
matrices. The conclusion is the matrices are biocompatible. We chose 10% PEDOT: PSS as
optimized group as a balance between conductivity and biocompatibility for further study.
4.3.3 Gene expression
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Figure 31. Impact of PEDOT: PSS on myogenic differentiation (gene expression)
To confirm the differentiation of cultured cells toward skeletal muscle, quantitative real-time
polymerace chain reaction (qRT-PCR) analysis was performed on four genes recognized as
important for skeletal muscle development (Figure 5). There was no significant difference in the
expression level of the Myf5 gene among the groups. However, other genes such as MyoD,
myogenic, troponin T, which are expressed at different stages of myogenic development,
respectively, were over-expressed on the 10% PEDOT:PSS substrate.Myf5 and MyoD
expression is initiated upon cell activation, and MyoD expression is sustained in proliferating
and differentiating progeny, while MyoG expression is associated specifically with late-stage
myogenic differentiation. Tnnt1 is associated with muscle contraction. There was a higher
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expression of myogenic regulatory genes MyoD, and MyoG, Tnnt1 on the electrically
conductive substrates compared to non- conductive substrates. The expression of almost all the
tested genes for cells cultured on electrically conductive substrates was two to four times higher
expression than cells from pure PCL substrates.
4.3.4 MHC/Dapi staining of matrices

a.10% D8

b.DOPA D8

c.PCL D8

Figure 32. Impact of PEDOT: PSS on myotube formation. Representative images of 8 days
MHC/dapi staining of C2C12 cells on (a) 10% PEDOT:PSS random electrospun nanofibers (b)
Dopamine random electrospun nanofibers (c) Pure PCL random electrospun nanofibers
We observed scattered formation of myotubes on the 10% PEDOT: PSS matrices and Dopamine
matrices after 3 days in growth media and 5 days in the differentiation media with minimal
myotube formation on the PCL only fibers (Fig. 9 a–c).
4.3.5 Satellite cell sorting using flow cytometry
The prospective isolation of purified stem cell populations has dramatically altered the field of
stem cell biology, and it has been a major focus of research across tissues in different organisms.
Muscle stem cells (MuSCs) are now among the most intensely studied stem cell populations in
mammalian systems, and the prospective isolation of these cells has allowed cellular and
molecular characterizations that were not dreamed of a decade ago[237].We followed a protocl
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that isolated MuSCs from limb muscles of adult mice by fluorescence-activated cell sorting
(FACS).
With this protocol, we isolate 250,000–350,000 quiescent MuSCs from hind limb muscles of a
healthy, wild-type C57BL6 mouse aged 2 weeks. This is approximately twofold to fourfold
greater than previously published protocols (ranging from 80,000 to 150,000 MuSCs per
mouse)16,17,25. The yield of MuSCs that we obtain represents ~3–4% of the total population of
mononucleated cells after antibody staining. The background signal in each channel when
sorting for MuSCs from mice within this age range is low, thus allowing distinct separation of
the VCAM1+Sca1−CD31−CD45− population (Fig.). When plated in culture conditions that
promote differentiation, >99% of the sorted cells are myogenic, as determined by the presence of
molecular markers, and >96% undergo terminal differentiation and fusion (Fig. ).
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Figure 33. Satellite cell isolation by FACs
We collaborated with Dr. Godhammer on isolating of mouse satellite cells. By FACs, we could
observe that only 14% of the whole cell population ended up being satellite cells.
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A

B

Figure 34.Phase micrographs depicting the morphology of mouse myogenic cultures seeded on
Matrigel-coated dishes on (A). Day 3 (B). Day 7

Cells were isolated by Pronase digestion and cultures were maintained in rich growth medium
according to protocols detailed in this chapter. Panels A, B, show the cultures on days 3, 7
respectively. Round cells observed during early culture days (A) are proliferating satellite cells.
Multinucleated satellite myotubes can be observed on day 7 (B).

4.3.6 Satellite cell immunochemistry(myotube formation after 7 days differentiation)
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Figure 35. Satellite cell immunochemistry (myotube formation after 7 days differentiation)
The identity of satellite cells can be further confirmed by their characteristic protein expression
using immunostaining with MF20/DAPI. A. Images were taken with a 20x
objective(MHC/DAPI). B. Bright field of satellite cells 20x objective. C. Images were taken with
a 10x objective (MHC/DAPI). D. Bright field of satellite cells 10x objective. It is observed that
multinucleated myotubes on day 7.
4.3.7 Cell proliferation on aligned electrospinning
10 mL of the PCL solution was placed into the syringe in the electrospinner with a 2.5 mL/min
flow rate, and 20KV at 15 cm distance at ambient temperature and humidity to obtain bead-free
nanofibers. A rotator was used to produce sheets with aligned nanofibers. After optimization, 6
V rotator voltage was chosen as optimum voltage for speed to produce consistent aligned
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nanofibers. Fiber diameter ranges from 2um to 5um. It falls the same range as random nanofibers
fabricated previously.

Figure 36. 2-day proliferation study on both align and random electrospun nanofibers.
The 2 Days C2C12 Cell proliferation study suggests that, generally, matrices that are fabricated
with aligned nanofibers may have better proliferation activity than matrices made with
randomly-oriented nanofibers. For instance, the aligned matrices treated coated with the
conductive polymer (10% PEDOT: PSS) held an average of approximately 94K cells attached,
whereas the randomly-oriented matrices with the same treatment only held on to an average of
57K cells.
The DOPA-PCL treatment groups followed the same pattern, with the aligned matrices housing
an average of 79K cells and the randomly oriented held only 54K.
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Figure 37. SEM images of aligned nanofibers(4000X).
This figure showed a representative image of nanofibers. By tuning the optimum condition, we
get nanofiber ranges from 2um to 5um, which is very consistent with what we got with random
electrospinning matrices.
4.3.8 factin/dapi staining of C2C12 cells on matrices
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a.10% PEDOT D8 Align

c. PCL D8 Align

b.10% PEDOT D8 Random

d. PCL D8 Random

Figure 38. Representative images of 8 days factin/dapi staining of C2C12 cells
(a) 10% PEDOT: PSS align electrospun nanofibers (b) 10% PEDOT:PSS random electrospun
nanofibers (c) Pure PCL align electrospun nanofibers (d) Pure PCL random electrospun
nanofibers
Factin and dapi staining showed that conducting polymer coated matrices supported cell
proliferation, which is consistent with previous observation. Alignment of nanofibers may
facilitate cell alignment than random nanofibers. The topographical cue combined with electrical
cues may facilitate growth and fusion of myotubes along their longitudinal axis.
4.3.8 Elisa expression
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Figure 39. Protein expression Tnnt1 D14 (random and alignment)
Since we know that conducting polymer promoted myoblast maturation, we further incorporated
topographical cues to the matrix. Using electrospinning, we fabricated aligned matrices with
fiber diameters in the same range as the random matrices.
To quantitatively assess the level of protein expression on different matrices, Tnnt1 was
measured at 14 days, after 11 days of post induction. In comparing all six groups, similar protein
expression levels were observed between the aligned and random dopamine groups as well as
aligned and random PCL groups, with the exception of aligned and random 10% PEDOT groups,
where the protein expression were significantly higher than the rest four groups (p<0.001).
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Aligned 10% PEDOT (A 10% PEDOT) showed slightly higher protein expression than randomly
aligned 10% PEDOT (R 10% PEDOT) but no significant difference was detected.

Figure 40. Normalized protein expression Tnnt1 D14 (random and alignment)
Assessing the normalized data, similar conclusion can be determined from these graphs. Aligned
10% PEDOT showed slightly higher normalized protein expression but no significant difference
was detected. This suggested a mild synergistic effect of topographical and electrical cues on the
differentiation of C2C12 myoblasts. Based on the study of a single factor (polymer conductivity)
as well as dual factors (polymer conductivity and matrix alignment), the addition of a conducting
polymer plays more important role in promoting myotube formation.
4.3.9 MHC/dapi staining on align and random electro conductive matrices

86

Figure 41. Representative images of 14 days MHC/PI staining of C2C12 cells
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on (a) 10% PEDOT: PSS align electrospun nanofibers (b) 10% PEDOT: PSS random
electrospun nanofibers (c) Pure PCL align electrospun nanofibers (d) Pure PCL random
electrospun nanofibers.
It has been shown on Figure 9A that conducting polymer nanofibrous matrices (10%PEDOT
align and 10% PEDOT random) promoted more myotube formation than PCL nanofibers (APCL and R- PCL). In addition, the incorporation of nanofiber alignment of 10% PEDOT aligned
nanofibers induced muscle cell alignment and also further enhanced myoblast differentiation
compared with the 10% PEDOT random nanofibers.
4.3.10 Quantitative analysis

Figure 42. Quantification of the myotube number, myotube length formed in (A) * p<0.05
significantly different.
By counting myotube numbers, aligned conducting polymer (A10% PEDOT) showed significant
higher (p<0.05) number of myotube than random conducting polymer (R10% PEDOT). It
showed more significant difference when compared with pure PCL nanofiber matrices (A-PCL
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and R- PCL). When using imageJ to measure muscle length, we discovered a significant
difference between A10% PEDOT to the rest of the three groups (p<0.005). A10% PEDOT
showed an average of 153.21 ± 56.56 µm length, while R 10% PEDOT showed an average of
95.97 ± 56.09 µm, A-PCL showed an average of 89.17± 56.09 µm, R-PCL showed an average of
47.03 ± 20.86 µm.
4.4 Discussion
Previous studies have shown that electrically conductive substrate hold great potential in tissue
engineering applications especially in neural tissue engineering[68][238][239][240][89]. Recent
advancements have shown that tissue engineering matrices made of conducting polymers such as
polyaniline[154][86], polypyrrole[104] or carbon nanotubes[241] can be used for localized
electrical signals to seeded cells, thereby resulting in an organized community of differentiated
muscle fibers[242]. Here the use of PEDOT: PSS further demonstrates that conducting polymer
coated matrices could promote myoblast maturation see in Figure 1. PEDOT: PSS has its
advantage due to its superior electrical, chemical and environmental stability as well as improved
conductivity and thermal stability[243][175]. In our endeavor, PEDOT: PSS coating was applied
on the modified PCL surface. It can be an alternative but straightforward approach to traditional
electrochemical method, where conducting polymers are usually deposited on hard
surfaces[244][245][246].It has been shown in our previous study this approach was stable and
successful[243]. Here dopamine polymerization was used not only to change surface
hydrophobicity but also to enhance myoblast adhesion to PCL. Since it is known that cell
reorganization, motility, and adhesion are greatly affected by substrate surface wettability[163].
It was discovered based on Figure 2, dopamine polymerization and PEDOT: PSS coating did not
affect nanofiber diameter. The concept is that the coating is stable and minimum coating of
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PEDOT: PSS could provide efficient conductivity. By altering PEDOT:PSS solution
concentration, it can be concluded that conductivity is directly correlated to PEDOT:PSS
solution concentration. As anticipated, the conductivity of a substrate composed of PCL only
was not in the detectable range, while matrices coated with PEDOT:PSS with the 100% group
possessing average sheet resistance values of around 5× 104 Ω/☐ , 33% around 13× 105 Ω/☐,
and 10% around 17× 106 Ω/☐. 1% group did not show consistent conductivity as the surface
coating concentraion might be too low. In this way, we may able to tailor the conductivity range
muscle cell desires. The effects of electrical cues on cellular morphology, proliferation were
studied using a cell viability assay, live/dead staining as well as SEM imaging. As shown in
Figure 4(A), the coated PEDOT:PSS was non-cytotoxic to the myoblasts cultured on all six types
of matrices. With optimum concentraion, which is 1% and 10 %, the conductive matrices
promoted cell proliferation for up to 14 days of culture shown in 4(B). SEM images of all six
groups showed that the cells were proliferting and spreading on the matrices in 4(C). This also
suggested that dopamine polymerized matrix may not be a significant factor in promoting
myotube formation although surface wettability has been changed. Furthermore, our results
demonstrate that myotube formation, which requires the differentiation of myoblasts, was
significantly influenced by the PEDOT: PSS coating at day 8 and day 14 in culture, as shown in
Figure 5. More myotube formation was observed on 1% and 10% PEDOT: PSS. This indicated
that under optimum concentration, Myoblasts expressed myosin heavy chain (MHC), a marker
for more mature skeletal muscle[247]and fused into multinucleated myotubes on the electrically
conductive substrates, with a greater number of multinucleated myotubes observed on the
electrically conductive matrices as well. To further quantitatively confirm differentiation of
cultured cells toward skeletal muscle, RT-PCR (Figure ) was conducted it was discovered that
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troponin T, which is a muscle contraction marker, was over-expressed on the 10% PEDOT: PSS
substrate. In addition, 10% PEDOT: PSS as well as dopamine group expressed significantly
higher MyoD than pure PCL substrates. Based on all these findings, we chose 10% PEDOT: PSS
for further study.
The potential mechanism might be that the addition of conducting polymer promoted regulation
of calcium levels within cultured myoblasts. Calcium is an intracellular messenger that plays
important role in muscle cells for excitation–contraction coupling, as well as for modulating
many aspects of cell physiology[248][163]. Yang et al. also discussed the fact greater
proliferation as well as maturation of skeletal myoblasts to electrical stimulation by conducting
polymer results may be regulated by L-type calcium channels present in the cell membrane. The
mechanism might largely be to due increased intracellular calcium channels[163].
Equally important, according to previous study, carefully designed nanotopography plays an
important role in establishing the structural organization required for the generation of
physiologically relevant and mature muscle tissues. Huang et al. indicated that myoblasts can
sense the nanoscale and microscale topographic features in the extracellular space, which could
facilitate cell orientation, interaction, organization as well as cell assembly[249].
We further incorporated the feature of alignment into conductive matrices. Both random and
aligned matrices were optimized at the same range of diameter (2 µm to 5 µm). When
quantitatively assess the level of protein expression on different matrices, significantly higher
Tnnt1 protein expression levels were observed on 10% PEDOT (both random and align).
Aligned 10% PEDOT (A 10% PEDOT) showed slightly higher protein expression than randomly
aligned 10% PEDOT (R 10% PEDOT) but no significant difference was detected.
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This suggested synergistic effect electrical cues on the differentiation of C2C12 myoblasts. The
alignment does not have a significant effect on the expression of myogenic proteins. However,
we cannot confirm that the feature of alignment is negligible.
Observation of the length and width of the myotubes is commonly used to detect myogenic
differentiation[109].It is observed that more and longer striated myotube formation on aligned
10% PEDOT: PSS matrices (A10%) In particular, the length of the myotubes formed on the
fiber substrates was significantly increased on the A10% compared to the rest three groups
(Figure 9A). The average length of the myotubes on the aligned nanofibrous A10% PEDOT was
50% longer than the myotubes on random 10% PEDOT: PSS matrices (R10%). This showed that
the conducting polymer may promote more myotube formation, but alignment helps form longer
and more mature myotubes. This observation confirms with previous study in other labs. For
example, Choi et al. reported that the length of myotubes derived from cultured human skeletal
myoblasts for 7 days was time times longer on aligned-PCL/collagen fibers (approximately 1000
mm) than on randomly oriented PCL/ collagen fibers (approximately 500 mm[152]. Huang et al.
and Jun et al. also observed myotubes increased significantly when cells were seeded on aligned
matrices[109][179]. Our observations suggest that fibers with electrically conductive properties
together with alignment features are effective at enhancing myotube formation.
4. 5 Conclusion
We have successfully developed a novel method for the fabrication of electroconductive
nanofiber matrices. The changes in myoblast maturation are here attributed to differences in
conductivity and topographies, rather than surface wettability on the substrates. Dopamine
polymerized PCL matrices may change surface wettablity but does not obviouly enhance
myotube formation. More importantly, the PEDOT: PSS coating of low and medium
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concentration (1% and 10%) were shown to induce increased expression of genes that play
significant roles in myogenic differentiation, indicating that substrate conductivity could play an
important role in engineering functional and biomimetic skeletal muscle tissues.
Overall, we have demonstrated that electrically conductive materials, in combination with
geometrically aligned electrospun nanofibers enhanced both myoblast differentiation and
ultrastructural organization without the need for external electrical stimulation. This could be of
great therapeutic benefit in clinical setting where severe muscle defect heavily affects volumetric
muscle loss or muscle atrophy in rotator cuff injury.
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CHAPTER 5. ROTATOR CUFF SURGERICAL MODELS
5.1 Surgery Background
Rotator cuff tears (RCTs) are the most common tendon injury seen in orthopedic patients. The
challenge is that massive RCT does not heal spontaneously and results in poor clinical outcomes.
Muscle atrophy and fatty infiltration in rotator cuff muscles are major complications of chronic
massive RCT and are thought to be the key factors responsible for the failure of attempted
massive RCT repair.
However, the pathophysiology of rotator cuff muscle atrophy and fat infiltration remains largely
unknown, and no small animal model has been shown to reproduce the histologic and molecular
changes seen in massive RCT.
Dr. Feeley’s group reported a novel rat massive RCT model, in which significant and consistent
muscle atrophy and fat infiltration were observed in the rotator cuff muscles after rotator cuff
tendon transection and denervation. Even after two weeks, the supraspinatus and infraspinatus
muscle lost 25.4% and 28.9% of their wet weight after complete tendon transection, respectively.
Six weeks after surgery, the average wet weight of supraspinatus and infraspinatus muscles
decreased 13.2% and 28.3%, respectively. Significant fat infiltration was only observed in
infraspinatus 6 weeks after tendon transection[211].
Dr Rubino’s group evaluated the changes in fatty infiltration of the rotator cuff after it is
repaired. The supraspinatus muscle of 15 New Zealand white rabbits was unilaterally detached
from the greater tuberosity. Six weeks after muscle detachment, 5 rabbits were killed to halt the
process of fatty infiltration and 10 rabbits underwent primary repair of the rotator cuff. Six
months after repair, the remaining 10 rabbits were killed, and the muscle specimens were
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examined microscopically to evaluate the muscle with respect to fatty infiltration. What they
found is that after repair of the rotator cuff, the process of fatty infiltration does not progress any
further. The changes that take place in this rabbit model in the first 6 weeks after a rotator cuff
tear appear to be irreversible even with successful rotator cuff repair. It has significant clinical
relevance that the presence of fatty infiltration of a torn rotator cuff does not preclude a
successful repair. The repair can prevent further progression and atrophy of the rotator cuff, but
the changes that appear in the muscle as early as 6 weeks after a rotator cuff tear appear to be
irreversible.
In a large sheep model done by Dr. Feeley ’s group, twelve female adult sheep underwent an
acute rotator cuff tear and immediate repair on the right shoulder. The left shoulder served as a
control and did not undergo a tear or a repair. After six months, the repair group demonstrated an
increase expression of muscle atrophy, fatty infiltration, fibrosis related genes. Significantly
increased adipocytes, muscle fatty infiltration, and collagen deposition was observed in rotator
cuff muscles in the tendon repair group compared to the control group. They found that rotator
cuff muscle undergoes degradation changes including fatty infiltration and fibrosis even after the
tendons are repair immediately after rupture[225]. Based on the literature of rat and rabbit model,
6 weeks of unrepaired rotator cuff, even they are repaired, the fatty infiltration is irreversible. For
sheep model, even acute repair of torn rotator cuff is done, the muscle atrophy is still occurring.
Even after the surgery, the quality and functionality of the muscle is very important. Here we
propose a biomaterial that can regenerate the muscle and prevent it from muscle atrophy.
5.2 Surgical technique
Two operations were performed on each animal: full-thickness supraspinatus tendon detachment
and complete tendon reattachment. Anesthesia was induced and maintained using 2% to 5%

95

isoflurane mixed with pure oxygen through a facemask for both procedures. The left shoulder
was operated on in all cases. A 1.5-cm skin incision was made directly over the anterolateral
border of the acromion. The deltoid was detached from the acromion and split caudally for 0.5
cm to identify the tendon of the supraspinatus. The supraspinatus tendon was completely
detached from its bone insertion on the humeral head, marked with a 5-0 Prolene suture
(Ethicon, Johnson & Johnson Medical Ltd., Berkshire, UK) at the musculotendinous junction,
and allowed to retract medially. Deltoid muscle, superficial fascia, and skin were closed with 5-0
Vicryl suture (Ethicon). Animals were allowed unrestricted cage activity and received analgesia
(subcutaneous buprenorphine) every 12 hours for 3 days. The second operation to reattach the
tendon was undertaken 3 weeks after the first procedure. Before the skin incision was made, the
DBM or GraftJacket was rehydrated for 30 minutes in sterile normal saline at the operating table.
A 2-cm skin incision was made in line with the supraspinatus muscle belly, ending anterior to the
lateral end of the clavicle. This approach was perpendicular to the incision used for tendon
detachment to make use of a virgin anatomic plane devoid of scar tissue. The muscle belly of the
supraspinatus was identified and followed distally to reveal the tendon stump with the suture
marker in the musculotendinous junction. Scar tissue between the tendon stump and its insertion
was excised, and the tendon was grasped with a double-armed 5-0 prolene suture using a
modified Mason-Allen technique.19 Despite traction on the tendon stump, it could not be
directly brought back to the humeral head in any of the cases. The bare tendon-bone insertion
footprint was decorticated with a No. 11 surgical blade until bleeding was seen. A custom-made
dental drill was used to drill a 1-mm hole from the neck of the humerus to the bone insertion of
the detached supraspinatus[218].
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A layered wound closure was undertaken in a similar manner to the first operation, and the
animals were permitted unrestricted cage activity. Postoperative analgesia (subcutaneous
buprenorphine 0.6 mg) was given every 8-14 hours for 3 days.
5.3 Results
5.3.1 Demonstration of surgical repair process

Figure 43.Exposure of Rotator cuff/Humeral head.
Incision centered over the aromion in line with the humerus then curving posteriorly towards the
spine of the scapula. Release Deltoid from acromion, undermine deltoid bluntly with tenotomy
scissors to release it from humerus to increase its mobility. Depress humerus to access the
subacromial space and expose RTC Tendons.
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Figure 44. Exposure of Supraspinatus Muscle Belly and application of Matrix
Palpate scapular spine, place belly of 15 blade scalpel against spine angled superiorly and release
trapezius (but not supraspinatus).
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Figure 45.Demonstration of continuity of supraspinatus muscle belly and tendon under the
acromion
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Figure 46.Mobility of the Humerus after releasing the Deltoid from the Acromion
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Figure 47. Demonstration of Deltoid, Supraspinatus tendon, Infraspinatus tendon, Subscapularis
tendon
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Repair

Figure 48.Repair of Deltoid to AC Ligaments
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Figure 49.Demonstration of tendon repair
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Figure 50.Bone tunnel shown by needle
5.3.2 Surgical complications
In general, surgery that involves anesthesia, which includes rotator cuff surgery, poses
complications listed as follows[250]: symptoms with light risk of stroke, heart attack,
pneumonia, or blood clot, damages to adjacent nerves and blood vessels, infection in the
shoulder. Besides, stiffness is common after rotator cuff surgery.
Currently, there is little information available concerning the outcome of patients with infection
after rotator cuff repair. Since we encountered surgical infections in our surgery process, we like
to retrospectively review the incidence. There are clinical presentation, bacteriology, treatment,
and outcomes of patients with rotator cuff repair complicated by deep infection.
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The diagnosis of deep shoulder infection was made at a mean of 49 days after the index surgery
(range, 2-483 days); the median time to diagnosis was 30 days. Of 39 cases, 15 (38%) presented
within 3 weeks, 14 (36%) presented at between 3 and 6 weeks, and 10 (26%) presented at more
than 6 weeks, with 2 presenting at 12 and 16 months[251].
The most common presenting symptoms included wound drainage in 28 shoulders, wound
erythema in 25, increased pain in 18, and partial or complete wound dehiscence in 12.
Seven patients presented with chronic mature sinus tracts with purulent drainage. Ten described
constitutional symptoms such as fever or chills at presentation.
Also, bacterial infection poses a threat to rotator cuff healing. According to the statistics,
polymicrobial infection was present in 6 cases, with the remaining 33 being monobacterial
[252][253].
Surgical infection observation
Surgery observation in chronic rotator cuff injury are written as follows:
1. Externally the skin appears well healed.
2. Upon incision, numerous fascicular connections are seen to connect the skin to
underlying musculature.
3. The suture-repair of the deltoid and trapezius at the acromion appear to be not completely
healed.
4. Inflammation and redness is observed around the acromion.
5. Likewise, major swelling is seen, making the area posterior to the acromion located
above and posterior to the humeral head bulged.
6. The surface of this bulge appears to have a combination of darkened read, greenish, and
yellowish coloration.
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7. Upon puncture of this bulged area, plain viscous liquid, or greening puree oozes (sepsis)
8. The bulge appears to be composed of scar tissue, careful removal of which reveals the
underlying bone, and tendon to bone repair.
9. In some samples, the suture through the bone tunnel has ripped out of the bone tunnel;
likewise, there is often a gap between the tendon foot and the bone to which it is attached
via suture. This gap is sometimes seen filled by scar tissue.
During our first surgery, there are two complications that are occurring infection rate and suture
coming out.

Figure 51.images of surgical infections with puss
The complication rate is listed as follows:
Group 1: (control 1) (0 out of 6) Sham surgery: 0%
Group 2: Acute repair (0 out of 8): 0%
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Group 3: tendon tear: (0 out of 8) 0%
Group 4: Rotator cuff acutely injured, 2 wks. later repaired with suture sacrificed at 2 wks. (2 out
of 4) 50%, at 6 wks. (2 out of 4) 50%
Group 5: Rotator cuff acutely injured, 2 weeks later repaired with suture and place 10% PEDOT:
PSS nanofiber matrices on supraspinatus muscle, sacrificed at week 2(2 out of 4) 50% , week 6
( 3 out of 4) 75%
Group 6: Rotator cuff acutely injured, 6 wks. later repaired with suture sacrificed at 6 wks.(0) 90
out of 4) 0%
Group 7: Rotator cuff acutely injured,6 weeks later repaired with suture and place 10% PEDOT:
PSS nanofiber matrices on supraspinatus muscle, sacrificed at week 2 (2 out of 4) (50%)

Infection rate
70.00%
60.00%
50.00%
40.00%
Series1

30.00%
20.00%
10.00%
0.00%
2 weeks later repair

6 weeks later repair

Figure 52.Infection rate of 2 weeks tendon tear and 6 weeks tendon tear only
According to the analysis, 2 weeks tendon tear and coming back to repair seems to cause more
infection. It makes perfect sense as we surgically tear the tendon and waited only two weeks to
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fix the rotator cuff. It has caused more trauma than doing good. That was the reason we later
decided to drop this surgery group.
Suture breaking out of the bone tunnel
During surgery process, we found several incidences that suture breaks out of the bone tunnel.
The number is listed as follows:
Acute repair: 1 out of 8
Sub-acute repair: 1 out of 24 (no infection)
11 out of 24(infection)

Incidence rate of suture breaking out
50%
45%
40%
35%
30%
25%
Series1

20%
15%
10%
5%
0%
Acute repair

Chronic repair without
infection

Chronic repair with
infection

Figure 53. Incidence rate of suture breaking out of bone tunnel

The reason why suture is breaking out of the bone tunnel might be mostly due to bacterial
infection.
Microbial infection usually caused by bone osteolysis (suture breaks out of the bone tunnel)
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Figure 54.X ray images of bone dissolving in one of the infected rotator cuff case

The X ray suggested that the part of the bone is gone potentially due to aseptic necrosis of the
humeral head. It occurs when part of the bone does not get sufficient blood and then dies. The
bone will further break out if the condition is not treated and will lead to potential collapse.
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After a while part of the bone breaks off. If this condition is not treated, bone damage gets worse.
Eventually, the healthy part of the bone may collapse. In our case, Aseptic necrosis can be
mainly caused by severe trauma as we have done intensive surgery procedures to a single rat
within short period of time.
Aseptic necrosis can be caused by many reasons such as disease, or a severe trauma, or even
break or dislocation, that affects the blood supply to the bone. Many times, no trauma or disease
is present. This is called “idiopathic aseptic necrosis” — aseptic necrosis without any known
cause[254].
5.4 Conclusions
In general, better precautions should be taken in order to prevent surgical infection. Here are
some measures we took during our follow up surgeries. It turned out to be successful: First of all,
we used antibiotics two days prior the surgery. We used one packet of equipment for each
surgery. Surgical gowns were changed every three cases. There was no touching other nonsterile equipment during surgery. Further, we exposed only shoulder side during surgery proper
cutting on the drape and performed less surgeries per day. We also tried to maintain the integrity
of blood vessels[251]. As discussed before, we decided to drop the two weeks tendon tear group
and then come back to repair as it doesn’t have too much clinical relevance.
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CHAPTER 6. EVALUATION OF BIOLOGICAL
PERFORMANCE of THE OPTIMIZED NOVEL
ELECTROCONDUCTIVE MATRICES IN RAT ROTATOR
CUFF MUSCLE ATROPHY MODEL
6.1 Introduction
Rotator cuff injury remains to be one of the most challenging orthopedic conditions that affect
more than 40% of elderly over 60 in the US [209,210]. Rotator cuff tears especially chronic
rotator cuff tears are hard to treat because of the injury time [210,255]. They are often associated
with a set of pathologic changes occurring in torn rotator cuff muscles, including muscle atrophy,
smaller muscle cross-section area, lipid accumulation in and around muscle fibers, larger
intramuscular spaces, and fibrosis [256,257]. These changes are referred to as ‘‘fatty
degeneration ” [223]. Despite successful repair of the tendon to the bone insertion site, the
clinical outcome is compromised by factors listed above [258]. For example, Goutallier et al.
demonstrated the high correlation of recurrent tear with advanced degrees of fatty atrophy among
220 patients [258]. A cohort study on rotator cuff retears rate after repair surgery is 7.22% and
fatty infiltration one of the primary reasons [255].
Therefore, preventing the adjacent muscle degeneration is critical to achieving favorable clinical
outcome after tendon repair. So far, multiple studies have been focusing on applying repair
techniques [215], using biologic factors [216] or biomaterials [217,218] to improve tendon to
bone healing.
At the same time, animal models are useful tools to study the molecular mechanisms of muscle
atrophy, fatty infiltration, and fibrosis that are observed in the setting of rotator cuff tears in
patients [225]. Much research has been done to study the progression of muscle atrophy
[213,225,258]. Various animal atrophy models such as rats [222], rabbits [259] or sheep [225]
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have been utilized to determine the timely changes that take place in the region of supraspinatus
muscle after tendon detachment [220,221]. It was hypothesized that tendon detachment would
lead to lack of load thus would cause significant muscle weight loss as well as a conversion of
the muscle types [222].
In summary, there is a need, and a gap for emerging strategies not only to provide effective
reinforcement of rotator cuff repair but provide novel treatment methods to enhance the patient’s
intrinsic healing potential[260].
It is the study interest that biomaterial strategies can potentially address muscle atrophy issue in
rotator cuff injury, which has not been well studied before. Biomaterials that containing
electrical cues is one of the new ways to change surface functionality as it can stimulate tissue
repair and regeneration [86]. Various studies showed a positive effect of conducting polymer
such as polypyrrole (PPy) [104], polyaniline (PANI) [261] in promoting myoblast
adhesion/proliferation [104]as well as maturation.
This could be revolutionary on how rotator cuff repair is being treated. In our study, the potential
effects of electrospun nanofibers containing conducting polymer PEDOT: PSS have been
previously explored in vitro and showed positive results [262]. Thus, the purpose of this study
was to evaluate how intrinsically conductive matrices stimulate muscle regeneration, thereby
suppressing fatty expansion.
6.2 Material and Methods
6.2.1 Study Design
In this study, we have developed a chronic rotator cuff repair model utilizing adult male Sprague
Dawley rats weighing between 400 grams to 450 grams. We first used an open surgical approach
to create a full-thickness rotator cuff tear of the supraspinatus tendon. After chronic (42 days)
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tear, we went back and performed surgical repair of supraspinatus tendon to 20 animals with or
without the insertion of PEDOT: PSS matrices at the same time. Briefly, during tendon repair, a
small incision is made through the trapezius muscle at the scapular spine, exposing the mid-belly
of the supraspinatus (SS) muscle. Then, a 0.6cm(length)*3 cm (width) PEDOT: PSS matrix was
sutured into the belly of the SS to induce a cycle of regeneration. Supraspinatus, infraspinatus,
and control supraspinatus tendon and muscle were exposed and removed for histological analysis
at specific time points after the procedure. We also performed an immediate repair to those acute
groups, that is we tear the tendon and then we immediately repair the injury. We then measured
changes in muscle mass, tendon length, and the number of fibers of fast type muscle and slow
type muscle. Differences between groups were tested using a one-way ANOVA followed by
Tukey's post hoc sorting. The surgical groups are listed as follows: Group 1: (control 1) Sham
surgery, sacrificed at two weeks(n=3) and six weeks(n=3). Group 2: (control 2): Rotator cuff
acutely injured without repair, sacrificed at week 2(n=4), week 6(n=4). Group 3: Rotator cuff
acutely injured, six weeks later repaired with suture, sacrificed at week 2(n=4), week 6(n=6).
Group 4: Rotator cuff acutely injured, six weeks later repaired with suture and place 10%
PEDOT: PSS nanofiber matrices on supraspinatus muscle, sacrificed at week 2(n=4), week
6(n=6). Group 5: Rotator cuff acutely injured, immediately repaired with suture and place 10%
PEDOT: PSS nanofiber matrices on supraspinatus muscle, sacrificed at week 6(n=6). Group 6:
Rotator cuff acutely injured, immediately repaired with suture, sacrificed at week 6(n=6)
6.2.2 Preparation
As previously described, Briefly, substrate material was electrospun using an optimized aligned
setup with electrospinning parameters of 15 % (w/v) PCL solution in ethanol and methylene
chloride (15:85 ratio). Dopamine (2mg/ml) was applied to the surface for 24 hours at pH 8.5 to
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polymerize onto the surface of the PCL fiber mats and form a polydopamine coating[115]. The
modified DOPA-PCL surfaces were washed, dried, and subsequently coated with 30 µl of 10%
PEDOT: PSS solution, where the 10% solution indicates a PEDOT: PSS 1.3wt% dispersion in
H2O and are further diluted ten times with PBS. The dried matrices were treated with mild
13.3% acetic acid, which is pH 2 to enhance its conductivity.
6.2.3 Tissue Harvest
Rats were sacrificed at 2 and six weeks after surgery. Both supraspinatus and infraspinatus of
surgical side and supraspinatus of control side were harvested, and the remaining tendon and scar
tissue were removed at the muscle/ tendon junction. The wet weight of muscle was weighed
immediately. The length of supraspinatus and infraspinatus were also measured at the time of
harvest. After the measurement was done, the harvested muscle was divided sharply into the
half. One was used for paraffin embedding, and the other half was used for frozen section.
6.2.4 Wet Weight measurement
The supraspinatus and control supraspinatus muscle were dissected origin along the
supraspinatus fossa of the scapula and the distal tendinous attachment. The wet mass of the
supraspinatus muscle was measured with use of a digital scale immediately after dissection
(Ohaus® Voyager Pro balance). Since sham group and tendon tear group are harvested at six
weeks post-surgery and two sub-acute repair groups are harvest 12 weeks post their first surgery.
We decided to use relative percentage weight change to measure the weight difference between
the different groups. The weight change percentage was calculated as
Relative 𝑝𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 𝑙𝑜𝑠𝑠
=;

control supraspinatus weight − supraspinatus weight
G × 100%
supraspinatus weigh
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6.2.5 Immunochemistry Analysis
Following existing protocol, between two and four cry sections (10 um-thick) cut from the mid
muscle belly will be rehydrated in phosphate-buffered saline (PBS), fixed in 4%
paraformaldehyde, washed in PBS, and immersed in 5% normal donkey serum for 15 min [233].
Above tissue sections will be imaged and quantified using immunohistochemistry for fast type II
myosin heavy chain (MHC) isoform, slow type I MHC isoform, and C/EBPa using fluorescence
labeling methods[233].
6.2.6 Histological Analysis
Muscle samples from all experimental groups were cut in half as previously described. The
entire half was fixed in 10% neutral buffered formalin and stored in 60% ethanol. All samples
were processed (ASP300S; Leica Microsystems, Bannockburn, IL) and then embedded in
paraffin (EG1160; Leica Microsystems). Eight to ten-mm-thick serial sections were cut from the
paraffin-embedded blocks and Masson's Trichrome staining, and Hematoxylin & Eosin staining
were performed to identify fibrotic tissue and muscle fiber outlines[232][233].
Immunohistochemical staining was performed using antibodies to detect fast myosin
(NovocastraTM Lyophilized Mouse Monoclonal Antibody Myosin Heavy Chain (fast), 1:10;
Leica Biosystems) and Vascular ECs were identified by immunohistochemical for Mouse
monoclonal [P2B1] to CD31(Abcam, Cambridge, MA, USA), regenerating muscle cells were
identified by Anti-NCAM antibody [RNL-1] (Abcam, Cambridge, MA, USA). Images were
captured and digitized (DM4000B Leica Upright Microscope; Leica Microsystems) at varying
magnifications.
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6.2.7 Muscle Cross Section Area quantification
To determine the muscle-fiber cross-sectional area, a transverse section of the supraspinatus
muscle was harvested from the different surgical group. Sections were embedded in paraffin as
previously described. Sections were visualized at X10 magnification (Leica Microsystems,
Wetzlar, Germany) and images were recorded with use of a digital camera. For Masson's
trichrome staining, all complete fiber structure were counted and measured. For fast muscle
staining, the cross-sectional areas of fifty random muscle fibers per muscle were selected. In both
ways, the selected muscle fibers were subsequently measured with use of ImageJ v1.32 imageanalysis software (National Institutes of Health, Bethesda, Maryland). Muscle samples were
analyzed in a random order, random selection and the investigator was blinded as to which
muscle was being analyzed as only particular serial numbers were given. All the selection with
their location information is stored in ROI manage in the form of Zip file for publication
purpose.
6.2.8 Muscle Gap quantification
After the tendon is torn in rotator cuff injury, there will be a massive gap between the tendon and
the bones, keeping the shoulder muscle from performing its usual actions of shortening and
lengthening. At the same time, the human body tends to fill the gap with fat instead of muscle
and this process is not reversible. However, the resultant outcome will be weak muscle with
reduced functionality. Clinically it cannot be fixed, but repair surgery can prevent fatty
infiltration from progressing further. Various studies have demonstrated that more fat will lead to
a higher the risk of suboptimal healing after rotator cuff surgery[263]. It is therefore essential to
quantify gap areas between muscle fascicles.
Fuji image j analysis is used in muscle gap quantification. We evaluated the effect of surgery by
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quantifying gap areas. Nine representative images with 350 µm * 350 µm dimensions were
selected from each group with their specific location labeled in ROI manager. The detailed steps:
1.

Open Fuji imageJ

2.

Go to Analyze – Set Scale

3.

Distance in pixels: 220 known distance 100 unit length um.

4.

Go to Edit- Selection – Specify

5.

Randomly crop 350 µm * 350 µm area and duplicate and save

6.

Go to Image – Split channels-Select only green channel

7.

Go to Image –Adjust –Threshold(85 to 255)

8.

Go to Analyze- Set Measurements-(select area, area fraction, mean gray value, limit to the threshold,
display label, add to overlay)

9.

Save the location of selection in ROI manager.

10. Go to Analyze and then click Measure
11. Save the area value and area percentage in excel file
12. Use prism for quantitative analysis

6.2.9 Statistical Analysis
6.2.9.1 Power Analysis
Power analysis was used to determine effective animal size in this study. It is the first time we
study muscle atrophy in rotator cuff model with matrices implantation. Preliminary data to see
the statistical difference was based on volumetric muscle loss(VML) with matrix
implantation[174]. In the calculation, treatment group percentage change was normalized with
control groups. Mean, and the standard deviation was then calculated. Power analysis was based
on 𝛼=0.05 and 𝛽=0.80. Then, a literature review was done to calculate effective animal size
under each index.
Muscle volume index
Page, R L et al. did an estimation of the regenerated tissue volume. They found 35% more mean
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total muscle area compared to untreated group by 30 days, 53.8% more mean total muscle area
compared to untreated group by 120 days.[264]
In another study done by Ward et al., they found that fifty percent graft repair significantly
increased fiber number by 20% compared with no repair. One hundred percent graft volume
repair resulted in a significant increase in fiber number compared with all other VML injured
muscles (e.g., *41% > nonrepaired), but did not achieve full fiber restoration (i.e., *14% <
contralateral uninjured muscle)[171].
In the study done by Y. Ju et al., they found that the number of regenerated muscle fiber
increased by 100% between matrices loaded with IGF-1 and control groups. [265]
Table 1. Muscle volume calculation based on literature review

sd
average

muscle volume calculation
1.35
1.41
2
0.359212101
1.586666667

Figure 55.Power analysis based on muscle volume index
Based on power analysis, n=4 is required if we do use this metric in our study.
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Pax7:
In the study done by Y. Ju et al., to identify the infiltrating cells, the retrieved matrices were
examined by immunohistochemistry for muscle progenitor cell marker, Pax7. Around 133%
increase between IGF-1 and control after two weeks.[265]
Another study was done by page et al., the treated implants for VML showed 100% more Pax 7
than untreated ones .[264]
In the study done by B.Corona, Pax7 was 13.3% higher from 1SPD to 1SP(media
condition)[206]
Table 2.Pax 7 indexes based on literature review
pax 7

average:
sd

2.33
2
1.33
1.886666667
0.509542278

Figure 56. Power analysis based on pax seven index
Based on power analysis, n=3 is required if we do use this metric in our study.
MHC
Immunohistochemical staining for MHC demonstrated newly formed muscle fibers, as
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evidenced by centrally located nuclei, in the defect site. Around 200% percent increase between
IGF4 and control group.[265]
Muscle weight index:
In the study done by Aurora, Amit et al. compared rat exercised and sedant after VML surgery:
The primary findings of the study are that physical rehabilitation in the form of voluntary wheel
running promoted around 13% increase in weight of the injured muscle. [266]
In the current standard VML model by Wu, resulting in significant compensatory hypertrophy of
the EDL. That is, the initial loss of approximately 20% of TA muscle mass was associated with
an approximate 15% and 17%increase in EDL muscle wet weight 2 and four months postinjury,
respectively. [204]
In the development of tissue-engineered muscle repair (TEMR) constructs (i.e., muscle-derived
cells [MDCs] seeded on an acellular bladder matrix (BAM) preconditioned with uniaxial
mechanical strain) for the treatment of VML. TEMR constructs were implanted into a VML
defect in a tibialis anterior (TA) muscle of Lewis rats and observed up to 12 weeks postinjury.
The BAM group showed a 12.8% increase in TA muscle weight compared to unrepaired
samples. [174]
Table 3.Muscle weight index based on literature review
muscle weight

average
sd

1.13
1.15
1.18
1.153333333
0.025166115
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Figure 57.Power analysis based on muscle weight index
Based on power analysis, n=1 is required if we do use this metric in our study.
As we can divide muscle into half for characterization, useful size n=4 is enough for each group.
6.2.9.2 Tukey pairwise comparison test
To quantitatively determine if there is a difference between the sham group, tendon tear group,
surgery repair groups with or without matrices, multiple images(6 to 9 images per group) are
pulled from representative images. Muscle cross-section areas are labeled as the mean and the
standard error of the mean. A p value of <0.05 was considered significant. Differences between
groups were determined using one-way ANOVA with Tukey's post test, or, where appropriate,
Student's t-test.
6.3 Results and Discussion
6.3.1 Tendon contraction
Table 4.Two weeks and six weeks tendon retraction
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2 weeks tendon retraction
Number of values
Minimum
25% Percentile
Median
75% Percentile
Maximum
Mean
Std. Deviation
Std. Error of Mean
Lower 95% CI
Upper 95% CI

6 weeks tendon retraction
10
5
6
6
7.25
8
6.5
0.9718
0.3073
5.805
7.195

15
5
6
7
7
10
6.733
1.163
0.3003
6.089
7.377

Tendon contraction was measured. It was listed as below:

Figure 58. Two weeks and six weeks tendon retraction
As the mean retraction for two weeks is around 6.5mm while meaning retraction for six weeks is
around 6.733 mm. Although six weeks the tendon retraction is slightly higher than two weeks,
there is no significant difference regarding tendon retraction between 2 weeks and six weeks. It
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is reasonable as once the tendon is retracted to some extent, it will not progressively retract
tremendously. However, the standard deviation of six weeks' retraction is higher than two weeks'
retraction.
We used reduced supraspinatus percentage to measure supraspinatus weight loss on the surgical
side compared to the nonsurgical side (Fig.58). The equations listed as follows: Reduced
supraspinatus percentage= (Control supraspinatus weight- surgical supraspinatus weight)/Control
supraspinatus weight.
6.3.2 Sub-acute rotator cuff repair
6.3.2.1 Wet supraspinatus weight measurement

Figure 59.Reduced supraspinatus percentage with Sub-acute repair six weeks
There were apparent gross morphometric changes in the muscle at 2 and six weeks following
surgery.
The supraspinatus muscles appeared noticeably smaller than the control muscle on the
contralateral side in the tendon tear only groups. Quantitatively, the reduced supraspinatus
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percentage of this tendon tear only group was statistically significant than other groups (at least
p<0.05) at two weeks as well as six weeks. For sham groups, they went through minimal
supraspinatus weight loss at two weeks compared to other groups. At six weeks, the wet weight
of surgical supraspinatus was higher than control supraspinatus, indicating possible complete
healing of muscle. It was noticeable that after rotator tendon being repaired, the difference of
weight loss between the surgical side and control side was much smaller than tendon tear groups
from two weeks to six weeks.
However, no significant difference was observed between sub-acute repair and sub-acute repair
with matrix groups in the reduced supraspinatus percentage regarding with the wet weight.

6.3.2.2 Histology Analysis
Fat cells were only observed in tendon tear groups. Indicating the successful repair can prevent
fat cells from proliferating.
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Figure 60. Fat cells proliferation of tendon tear group 6 weeks
For the tendon tear only group, more gaps were observed between muscle fascicles. Fat cells
start to
infiltrate and proliferate between these muscle gaps.
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H&E staining

Masson’s trichrome

Figure 61. Significant Fibrosis on six weeks tendon tear group
Based on the Figure, more fibrosis was observed on tendon tear the only group both in H&E
staining and Masson's Trichrome staining.
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Figure 62. MyHC II fibers (fast muscle type) staining on tendon tear the only group
Consistent with the result in H&E staining and Masson’s staining, more fibrosis were observed
on tendon tear groups six weeks post-surgery.

A. Sham group

B. Tendon tear only

C. Sub-acute repair with
suture

D. Sub-acute repair with
matrix

Figure 63 H&E staining Sub-acute repair 2wks

Hematoxylin and eosin staining of the rat supraspinatus muscle (Fig 63. Demonstrated
morphologic changes in the transected rotator cuff muscle compared to control sham groups. The
muscle cross sections were smaller after six weeks tendon tear compared to the sham group, with
increased fibrosis of and irregular muscle structure. There is fibrosis present in both sub-acute
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repair groups but not as significant compared with tendon tear only group. The muscle fiber
looked organized and short 6 weeks after successful surgical repair. (Figure below) demonstrates
fast muscle growth on a matrix, indicating potential muscle regeneration on electrically
conductive matrices.

Figure 64. H&E staining Sub-acute repair 6wks
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Figure 65.Masson Trichrome staining of different groups at 2wks
Mason Trichrome staining showed similar study result that tendon tear groups had wider gaps in
between and had more fibrosis. The packing and orientation of muscle fibers are more regular in
Sub-acute repair with matrix group then suture group alone.
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Figure 66.Masson Trichrome staining of different groups at six weeks post-surgery
Six weeks Masson Trichrome staining further confirmed by showing dense packing of muscle
fibers in groups which were repaired with matrices
Muscle gap area quantification
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Figure 67.Masson Trichrome staining of different groups at six weeks post-surgery
As previously described, we used ImageJ to convert Mason image to a binary scale, in this way
we can quantify the percentage of the gaps.

Figure 68.Gap Area between Muscle Fascicles 6 weeks sub-acute repair
After the tendon is torn in rotator cuff injury, there will be a considerable gap between the tendon
and the bones, keeping the shoulder muscle from performing its usual actions of shortening and
lengthening.
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Various studies have demonstrated that more fat will lead to a higher the risk of suboptimal healing
after rotator cuff surgery [263]. The quantification of these intrafibrillar spaces also termed as gap
area here is, therefore, an essential indication of muscle atrophy.
Tendon tear only group had more gap between muscle fascicles with mean gap percentage around
20.34%, which was statistically higher than the rest of the groups. Sham group had smallest gap
area with low 5.367%. It also showed a statistical difference compared with the rest three groups.
Sub-Acute repair with matrix had less gap percentage (9.823%) than Sub-Acute repaired with
suture repair only (15.14%) (p<0.01). The potential mechanism was that with the aid of matrices,
the stimulus effect prevented muscle gap from forming so that the average muscle area was more
significant compared with suture only group.
Below is the result of a Tukey test of pairwise comparison and degree of significance
Table 5.Tukey test of pairwise comparison on Gap Area between Muscle Fascicles 6 weeks
sub-acute repair groups

Tukey's multiple

Mean Diff.

comparisons tests

95.00%

Significant? Summary Adjusted P

CI of

Value

diff.
Sham group vs. Tendon

-14.97

Tear
Sham group vs. Sub-

acute repair(matrix)

Yes

****

<0.0001

-10.84
-9.777

acute repair with suture
Sham group vs. Sub-

-19.11 to

-13.98 to

B
Yes

****

<0.0001

-5.571
-4.457

-8.662 to
-0.2507

A-

AC

Yes

*

0.0341

AD
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Tendon tear only vs.

5.196

Sub-acute repair with

1.264 to

Yes

**

0.0053

9.129

BC

suture
Tendon tear only vs.

10.52

Sub-acute repair(matrix)
Sub-acute repair with
suture vs. Sub-acute

6.585 to

Yes

****

<0.0001

14.45
5.321

1.311 to

BD

Yes

9.331

**

0.0051

CD

repair(matrix)
Muscle cross-section area using Mason's Trichrome staining
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Figure 69.Muscle cross-section area using Mason's Trichrome staining
The muscle-fiber cross-sectional area decreased at six weeks from 2905 ± 134.3 um2 in sham
group to 1421± 100.9 um2 (p<0.0001) in tendon tear only group, from 2905 ± 134.3 um2 in sham
group to 1629± 94.81 um2 (p<0.0001) in sub-acute repair with suture group and 2905 ± 134.3
um2 in sham group to 1983± 88.06 um2 (p<0.0001) in sub-acute repair with suture. Sub-acute
repair with matrix (1983± 88.06 um2) has higher muscle cross-section area compared with subacute repair with suture only (1629± 94.81 um2, p<0.001). The degree of cross-sectional area
reduction was dramatic in tendon tear the only group.
Based on the result, it is discovered that the sham group has the highest average muscle cross-
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section area compared with rest of the three groups(p<0.0001). Tendon group has the smallest
muscle area compared with sub-acute repair with suture or Sub-acute repair with
matrix(p<0.001). Sub-acute repair with matrix has a higher muscle cross-section area compared
with sub-acute repair with suture only. This suggested that prevention of muscle from shrinking
is achieved with the aid of matrix. It is also consistent with muscle gap quantification.
Fast muscle staining

A. Sham group

B. Tendon tear only

C. Sub-acute repair with
suture

D. Sub-acute repair with
matrix

Figure 70.Fast muscle staining sub-acute repair at two weeks’ time point
At two weeks, in the thick tissue layer, all groups have both fast muscle and slow muscle.
However, fast muscle has a dominant percentage (stained brown compared to those unstained).
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A. Sham group

B. Tendon tear only

C. Sub-acute repair with
suture

D. Sub-acute repair with
matrix

Figure 71.Fast muscle staining sub-acute repair at six weeks’ time point

Until six weeks, the slow muscle has almost disappeared in the tendon tear group. It is consistent
with previous literature that MyHC I fibers (slow muscle type) are more are more vulnerable to
atrophy induced by external forces such as denervation as well as immobility because they have
a higher protein metabolic rate. MyHC II fibers (fast muscle type) are more sensitive to
cachexia, chronic heart failure, chronic obstructive pulmonary disease as well as aging[267].
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Figure 72. Type I muscle composition change from 2 weeks to 6 weeks
According to MyHC classification of muscle fibers, MyHC I, MyHC II correspond to muscle
fiber Types I, II [267]. It was observed that the majority of the rotator cuff muscle fibers in the
rats were made up of Type II (fast). MyHC II staining which was shown in brown while MyHC I
fibers was left unstained and showed white. Until six weeks, the slow muscle had almost
disappeared in the tendon tear the only group. It was consistent with previous literature findings
that MyHC I fibers (slow muscle type) are more vulnerable to atrophy induced by external forces
such as denervation as well as immobility because they have a higher protein metabolic rate.
MyHC II fibers (fast muscle type) are more sensitive to cachexia, chronic heart failure, chronic
obstructive pulmonary disease as well as aging [267]. At two weeks, in the thick tissue layer, all
groups had both fast muscle and slow muscle. However, fast muscle had a dominant percentage
(stained brown compared to those unstained).

Consistent with what we saw in the images in Figure 6A, there was less type I muscle in all the
groups as they are susceptible to injury Figure 6B. Tendon tear the only group had the smallest
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type I muscle percentage. Unstill six weeks, Tendon tear only group still had the lowest type I
percentage while sham group and Sub-Acute repair with suture with or without matrices showed
an increase in type I muscle. Sub-Acute repair with matrices showed a statistical difference
compared with the tendon tear only group.

Muscle cross-section area using fast muscle staining
A.

B.
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Figure 73. A. Muscle cross-section area statistical measurement between different groups at six
weeks' time point. B. Random selection of 50 muscle fibers with three replicates in each group.
For each group, 3 to 4 representative images were selected, and we randomly selected fast
muscle fiber cross section area for measurement. We can find that sham group (3548± 92.06
um2) showed statistically higher fast muscle fiber area than the rest three groups. Tendon tear
group (1836± 92.06 um2 ) has the smallest average fast muscle cross-section area compared with
two sub-acute repair group(p<0.001). Sub-acute repair group with suture (2618 ± 92.22 um2) has
no significant difference compared with Sub-acute repair with matrix (2724 ± 92.37 um2), but it
showed a slightly higher fast muscle cross-section area. The reason for fast muscle area higher
than Masson's staining measurement is that Masson's staining accounts for both types of muscle
fibers. Also, the quantification method can be further improved.
The progress of muscle cell infiltration
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A. Sub-Acute repair with matrix
2wks

B. Sub-Acute repair with
matrix 6 wks

Figure 74.Fast muscle cells infiltration on electroconductive matrix from two weeks to six
weeks.
The host response to muscle atrophy treated with conductive electrospun nanofiber matrix was
characterized by a dense infiltration of both neutrophils and mononuclear cells that surrounded
and populated at the outer edges of the matrix at two weeks' time point. After six weeks, the
electroconductive implant was more acellularized identified by more fast muscle growth in the
center of matrices.

Figure 75.Fast muscle infiltration on the Sub-acute repair with matrix six weeks post-surgery. A.
Low magnification (left panels) shows 10X magnification. B. High magnification (20X) (right
panels) shows
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Based on this figure, native skeletal muscle (fast muscle) ingrowth could be identified in the
center of matrix margins. This showed that this aligned conductive matrix could support muscle
regeneration and growth.

Figure 76.High magnification (20X magnification) shows fast muscle growth on matrices
This figure further demonstrates that quite a lot of native skeletal muscle (fast muscle) ingrowth
could be seen on the matrices.

CD 31 staining
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CD 31 staining

Figure 77. Matrices implanted on muscle tendon tear only and repair with matrices 6weeks
post-surgery
The H&E staining supported similar claims that the conductive matrix was almost wholly
cellularized, showed islands of desman + cells along the interface with the underlying native
muscle.
Muscle vascularization on matrices
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Figure 77.Sub-acute repair with matrix six weeks post-surgery. A. A region where matrices were
implanted B. Other regions

Traumatic injury in skeletal muscle will lead to loss of blood supply at the injury site. However,
blood vessel plays a vital role in carrying nutrients and oxygen to the cells. In skeletal muscle,
myoblasts have limited ability to proliferate and differentiate if they are more than 150 mm away
from the blood vessel. Revascularization in the regenerative engineering is a critical step towards
achieving successful regeneration of skeletal muscle[2]. Here based on the image of six weeks
post-Sub-acute repair with matrix group, we can discover that more vascularization was present
where matrices are inserted compared to the region where there are no matrices. This indicates
the presence of matrices will require stimulation revascularization and promote muscle
regeneration.
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6.3.3 Acute rotator cuff repair
6.3.3.1 Wet supraspinatus weight measurement

Figure 78.Reduced supraspinatus percentage with Acute repair six weeks
After six weeks, relative reduced supraspinatus percentage of the tendon tear only group (is
statistically significant then acute repair (both with or without matrix). We can also observe that
if the tendon is left untreated (14.86%)., it showed the very significant difference with the sham
group (-1.983%, p<0.001). While the sham group showed significant with both repair
groups(p<0.01). The tendon tears the only group also showed the statistical difference between
two acute repair groups(P<0.05). There was no statistical significance between acute repair with
suture (7.44%)
Moreover, acute repair with matrix (8.14%). We can draw a similar conclusion that once the
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tendon is being repaired, it showed better improvement than the tendon tear only group.
6.3.3.2 Histology Analysis

Figure 79.Hematoxylin and eosin staining of the rat supraspinatus muscle six weeks of acute repair
Hematoxylin and eosin staining of the rat supraspinatus muscle showed most of the fibrosis on
tendon tear group. The muscle cross sections were smaller after six weeks tendon tear compared
to the sham group, with increased fibrosis of and irregular muscle structure. There is fibrosis
present in both sub-acute repair groups but not as significant compared with tendon tear only
group. Both acute groups showed better muscle organized six weeks after successful surgical
repair.
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A. Sham group

C. Sub-acute repair

B. Tendon tear only group

D. Sub-acute repair
with matrix

Figure 80.Masson Trichrome staining of different groups at 6wks acute repair
In the six weeks Masson Trichrome staining, a sham group has the most regular muscle structure
and packing. Tendon tear group has wider gaps in between. It is further confirmed by showing
dense packing of muscle fibers in groups which were repaired with matrices.
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Figure 81.Gap area between muscle fascicles six weeks acute repair
Similar to the sub-acute repair groups, tendon tear group had more gap between muscle fascicles
with mean gap percentage around 20%, it was statistically higher than the rest of the groups.
Sham group had the smallest gap area with mean 5%. It also showed a statistical difference
compared with the rest three groups. Acute repair with matrix has slightly less gap percentage
(10%) than sub-acute repair with suture repair only (15%) (p<0.01). The potential mechanism is
that with the aid of the matrix, the stimulus effect prevents muscle gap from forming so that the
average muscle area is more significant compared with suture only group.
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Figure 82.Cell infiltration on matrices after six weeks acute repair A. H&E staining with
matrices(5X) B. Masson Trichrome staining with matrices(5X) C. H&E staining with
matrices(10X) D. Masson Trichrome staining with matrices(10X)
Both H&E staining and Masson Trichrome staining showed that the conductive matrices were
almost wholly cellularized, showed islands of desman + cells along the interface with the
underlying native muscle.
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Figure 83.Acute repair with matrix six weeks post-surgery. A. The region where matrices were
implanted (5X) B. Other regions in supraspinatus muscle(5X) C. Region where matrices were
implanted (10X) D. Other regions in supraspinatus muscle(10X)
Similarly, based on the image of six weeks post-acute repair with matrix group, we can discover
that more vascularization was present where matrices are inserted compared to the region where
there are no matrices. This indicates the presence of matrices will require stimulation
revascularization and promote muscle regeneration.
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Figure 84.Fast muscle infiltration on the acute repair with matrices six weeks post-surgery. A. Low
magnification (left panels) shows 5X magnification. B. High magnification (10X) (right panels)

Based on this figure, traces of native skeletal muscle (fast muscle) ingrowth could be identified
along the edges of matrices. This showed that this aligned conductive matrix could support
muscle regeneration and growth.
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Figure 85.Muscle cross section measurement at six weeks using fast muscle staining
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Similarly, we can find that the sham group showed statistically higher fast muscle fiber mean
area of 3548± 91.84 um2 than the rest three groups(p<0.0001). Tendon tear group has a mean
area of 1836 ± 91.99 um2. It has the smallest average fast muscle cross-section area compared
with two acute repair group(p<0.001). Acute repair group with suture (mean 2430 ± 91.99 um2 )
has no significant difference compared with acute repair with matrices (mean 2537± 92.14 um2
um2).
6.4 Conclusions
We have successfully developed a sub-acute rotator cuff repair model for our study.
The results have demonstrated that detached supraspinatus muscle in this rat model changes
significantly, with a decrease in muscle mass, a decreased cross-sectional area, and an increase in
fat content. Type I muscle composition were deficient at two weeks' time points, but the sham
group, Sub-Acute repair with matrix and Sub-Acute repair with suture only group were able to
recover more type I muscle than the tendon tear only group. Besides, we showed that the
increase in fat exhibited in the injury only model with a spatial pattern closer to the tendon
attachment as compared with proximally.
It was observed in our study that even there was a delay in surgical repair, overall muscle quality
such as muscle fiber cross-section area and muscle irregularity can be improved, and there was
less fibrosis compared to the tendon tear only group. Furthermore, the primary hypothesis of the
current study is that by placing electroconductive matrices in the supraspinatus muscle after
successful surgical repair, it can have a stimulating effect to promote muscle bundles to grow
bigger. In this way, fatty infiltration is suppressed to some degree. So far, the positive impact of
conducting polymer to promote muscle growth and differentiation have been confirmed in vitro
by multiple research groups[5,104,109]. In our study, it was also observed that Sub-acute repair
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of rotator cuff injury with electroconductive matrices revealed robust muscle growth and
vascularization.
We were the first one to test the hypothesis in vivo. The result showed a favorable outcome.
Besides, previous studies have demonstrated that initial response to matrix implantation includes
dense mononuclear cell infiltration which peaks at approximately two weeks post-surgery. The
trend will be gradually decreasing afterward [20,21]. This cellular infiltrates mainly
macrophages, the activation and temporospectral polarization of which is essential for muscle
regeneration[208,268]. This progress will be followed by migration of myogenic progenitor to
the injury site as a result of cytokines and chemokines released by the invading
macrophages[208,268]. In our study, cell infiltration was observed two weeks post-surgery and
continued to subside by six weeks following surgery. The matrix is acting as ‘stabilizer' to make
supraspinatus muscle in place and prevent the formation of the gaps. Also, there were more
vascularization as well as regenerated muscle cells growing on implanted electroconductive
matrices at six weeks after surgical repair, indicating potential effect of matrices stimulating
muscle growth following aligned electrospun nanostructure. Future study can also be done to
explore that delay time between tendon tear and repair. For matrix repaired groups, there was
less muscle gap and slightly higher muscle cross-section area compared with suture repair only.

152

Chapter 7. INTRODUCTION, CONCLUSIONS, AND FUTURE
DIRECTIONS
7.1 Introduction
The field of regenerative muscle tissue engineering has come to provide the essential foundation
for the next generation of clinically viable muscle graft substitutes. At the same time, the rising
of conducting polymer has shown great promise in muscle as well as neural tissue
regeneration[78][269][154]. As discussed in the introduction chapter, matrices were made
biocompatible and biodegradable. Also, they are being combined with growth factors, drugs or
morphogenetic proteins and cells. This combination of matrices, cells, chemical, morphological
and biological features are critical elements in regenerative tissue engineering. Based on all those
experience, the ambition in the scope of this research is to have more efficient conductive
matrices with improved biological performance both in vitro and in vivo.
The work in this thesis on electroconductive matrices have moved through the initial stages of
a conductive polymer coating, modification, characterization, in vitro degradation, preliminary
cellular evaluation, and intensive in vivo study and characterization. The broad hypothesis
behind the design of this matrix was in part to capitalize on the benefits of both the alignment
feature of electrospinning and optimum concentration of conducting polymer that would enhance
the cell proliferation and encourage muscle differentiation. The initial analysis of this approach
has been completed. After a careful assessment in vitro, we further evaluated the matrix in small
animal’s models to evaluate the matrices performance, which is crucial for translational research.
7.2 Conclusions
In the scope of the thesis, a novel conducting polymer conducting polymer was successfully
fabricated. A series material characterization was done to ensure the fabrication process was
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successful and can be repeated. It was discovered that a combination of various guidance cues in
the same matrix might provide a more biomimetic environment for tissue regeneration that is
superior to inert matrices such as PCL matrices. Such electrospun composite nanofibers can
simultaneously provide topographical and electrical cues to cells, highlighting the importance of
the synergistic effects of these stimulatory cues for skeletal muscle tissue engineering. Then we
used this optimized matrix for clinical study in rotator cuff models. Surgery wise, we found that
it is better to treat rotator cuff injury promptly. However, even there is a delay in treating tear,
the result suggested after a successful repair, the muscle condition, in general, was better than
those untreated tendon tear groups. Also, regenerated muscle cells were growing on implanted
electroconductive matrices at six weeks after surgical repair based on histology results,
indicating the potential effect of matrices stimulating muscle growth following aligned
electrospun nanostructure. Based on these results, it is very promising that a complex conducting
polymer system, in a combination of electrical stimulation and satellite cells and deliver growth
factors, can help further treat muscle atrophy in rotator cuff injury.
7.3 Future directions
Based on the study of muscle defect, there are two tracks that we can potentially pursue in the future.
We can further improve the current system with muscle atrophy in rotator cuff model. An optimum
amount of satellite cells and growth factors can be seeded on those electroconductive matrices to
promote a higher level of regenerative properties. Besides, localized electrical pulse stimulation
(EPS) mimicking the electrical cues in the in vitro niche, can be applied at localized muscle area to
further promote myogenic differentiation of myoblasts and satellite cells on the matrix. Besides, in
this study, we created a sub-acute repair model. Future modifications may include having a longer
defect creation time, say three months or more. In that sense, we can see the effect of matrices on
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chronic repair. Another pitfall of the current study is that the observation time after surgery is too
short. The matrices of the current research study already showed great compatibility and
regenerative properties. It is expected that better surgical healing will be shown after three or more
months post-surgery.
We can further expand the project to volumetric muscle loss (VML). It is a hallmark of orthopedic
traumatic or surgical loss of skeletal muscle with resultant functional impairment and no current
standard of care[270][271]. More than 40% of the human body's mass consists of skeletal muscle,
which possesses the ability of robust self-repair after injury[230][2]. However, when a large volume
of muscle is lost as a result of trauma, the ability of skeletal muscle to regenerate usually fails[202].
Trauma causes a tremendous burden of disease and injury all over the world. In the United States
alone, it was shown that more than $400 billion was spent annually in association with medical costs
and loss of productivity[200][272].
Further, the majority of the trauma during combat operations in Iraq and Afghanistan is to the
extremities and often associated with severe musculoskeletal injury[200]. The cost is tremendous
because not only money was spent on treatment and rehabilitation, but also there is a separation of
highly trained personnel from the military[273].
The current standard approach for volumetric muscle loss is to use functional free muscle transfer.
Although it looks promising, the procedures are complicated. The successful outcome of the surgery
depends on highly skilled team member and proper patient location. What is worse, donor site
morbidity issues and expertise to perform these surgeries poses a limitation to its widespread use.
Last but not least, the results of usage of free tissue transfer have not always been promising for
patients with combat extremity injuries[2][201]. Advances in the use of tissue engineering matrices
and stem cells, hint at future therapeutic. However, the use of biologic matrix alone is limited
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because it requires the presence of a nerve and remaining muscle construct[201]. Thus, it is critical
to developing a newly engineered complex system that could regenerate a lost muscle part,
improving the quality of life of thousands of veterans of the US considerably. Here we propose to
apply a regenerative tissue engineering method as an alternative approach not only to preventing
scar tissue formation and restoring muscle function in moderate injuries, but also offering a highly
potential treatment option for patients with a large volume muscle loss[2]. It is our vision to explore
top-down engineering approaches using matrix-based tissue engineering in combination with the
latest developments in stem cell science, developmental biology, and electric stimulation to study
the muscle regeneration.
Experience learned from matrix-based tissue engineering can, when incorporated with
developmental and stem cell-based biology, controlled growth factor releases, and electrical
stimulation, be applied to the regeneration of muscle constructs.
In our previous study, we successfully fabricated conducting polymer coated matrices. Both aligned
and random electrospun nanofiber matrices are formed using 15 % (w/v) poly (ε-caprolactone) (PCL).
Then dopamine is applied to the surface for 24 hours at pH 8.5 to polymerize onto the surface of
PCL fiber mats, forming a polydopamine coating. This polydopamine coating can help to enhance
the affinity of PCL fiber mats to muscle cells. Different concentrations of poly
(3,4ethylenedioxythiophene): poly (styrene sulfonate) (PEDOT: PSS) (1%, 10%, 33%, 100%) were
deposited onto surface-modified electrospun nanofiber matrices. Electroconductive nanofiber
matrices with tunable conductivity were successfully achieved. Further, based on an accelerated rate
of innervation of skeletal muscle in a severe hindlimb ischemia model by treating with IGF or
VEGF[136], It is further hypothesized that incorporation of growth factors such as IGF or VEGF
into matrices can further improve healing of VML.
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Based on our preliminary study, it has been shown that even without external electrical stimulation,
conducting polymer matrices have promoted more myotube formation, and alignment has helped
form longer and more mature myotubes. It is further hypothesized that electrical pulse stimulation
(EPS) mimicking the electrical cues in the in vitro niche, will further promote myogenic
differentiation of myoblasts and satellite cells on the matrix.
Also, we hypothesize that a conducting polymer system, in a combination of electrical stimulation,
can efficiently carry satellite cells and deliver growth factors, can help muscle regeneration in VML
model (see Figure 3). We will first isolate satellite cells, seeded it on conducting polymer matrices,
which already incorporated growth factors. Then the complex matrix will be inserted into VML area,
and proper electrical stimulation following protocol will be given.

Figure 86.Schematic illustration of approaches of multi delivery matrix system and electrical
stimulation to treat volumetric muscle loss
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7.4 Objectives
The specific objectives of this proposal are:
Aim #1: Fabricate a PEDOT: PSS/PCL composites matrices releasing growth factors.
Our lab has successfully demonstrated that electrically conductive materials, in combination with
geometrically aligned electrospun nanofibers enhanced both myoblast differentiation and
ultrastructural organization without the need for external electrical stimulation. We will further
incorporate factors such as IGF or VEGF into matrices by either co-electrospinning or surface
absorption. The release profile will be characterized using Elisa or HPLC. Toward this goal, in the
end, we will be able to have controlled the release of the growth factor in this biodegradable
electrically conducting matrix /growth factor system. The controlled release matrices will be
characterized using Scanning Electron Microscopy (SEM), X-ray photoelectron spectroscopy (XPS),
and contact angle analysis. The effects of topographic cues, electrical cues, and growth factors cues
on cellular morphology, proliferation, and myogenic differentiation will be studied using a cell
viability assay, live/dead staining, proliferation (MTS, DNA assay or Ki67), RT-PCR (Real-Time
Quantitative Reverse Transcription PCR) and immunohistochemistry 3.
Aim# 2: To evaluate the in vitro effects of electrical stimulation on satellite cells proliferation and
differentiation cultured on the aligned electrically conducting matrix.
Satellite cells, an adult stem cell population are capable of regenerating new muscle[136]. Using an
established protocol for satellite cell isolation, we will harvest satellite cells from rats and seed them
on electroconductive matrices. According to previous protocol, continuous EPS parameter ranging
from 0.1–0.5 V/mm pulse amplitudes, 0.5–2 Hz frequencies will be applied[274]. Force production
characterized using physiological parameters such as peak twitch force (Pt) will be recorded and
analyzed[274]. The effects of electrical stimulation on cellular morphology, proliferation, and

158

myogenic differentiation will be studied using cell viability assay, live/dead staining, RT-PCR
(Real-Time Quantitative Reverse Transcription PCR) and immunohistochemistry. At the end of this
aim, we will be able to evaluate and determine the efficacy of electrical stimulation on myogenic
differentiation in vitro using an established protocol.
Aim#3: To assess the cellularity and muscle formation of the electroconductive nanofiber matrix
determined in standard VML rat model in vivo under electrical stimulation and stem cell, growth
factor delivery.
Rat TA muscle VML injury will be created. Briefly, a punch biopsy will be performed through the
middle third of the TA muscle, and around 20% biopsied tissue will be removed[171]. Multi
delivering muscle cell patches created and improved in aim 1 and aim two will then be transplanted
in the defect area. Then electrical stimulation will be applied to treatment groups. Specimens (n=6)
for In vivo functional assessment will be performed. In brief, in vivo neural evoked torque of isolated
TA muscles will be measured between VML rats treated with electrical stimulation and VML control
rats[171]. To assess engraftment, rats will be euthanized, and muscles will be harvested at four
weeks and eight weeks post-transplantation for analysis. Muscle histology sections will be stained
with hematoxylin and eosin (H&E), and oil red O, to assess tissue structure cellularity as well as fat
deposition(n=3)[171]. At the end of this aim, we will have established the efficacy of a
biodegradable electrically conducting matrix/stem cell/growth factor system with electrical
stimulation in healing a volumetric muscle loss. We expect that the mechanical stability and ES
offered by the degradable matrix and the delivery of stem cells, growth factor would significantly
improve the functionality of muscle.
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7.5 Impact of the project
Muscle conditions are not to be neglected. The impact of VML on the general population is
significant as muscle conditions rank among the top 10 most frequent unfitting conditions[271].
According to the U.S. Army Institute of Surgical Research, in an orthopedic-specific population
(limb salvage type III tibia fracture) muscle conditions (VML) account for 65 percent of disability.
Failure to address those soft-tissue deficits could result further in poor surgical recovery. VML
contributes to >90 percent of muscle conditions that lead to long-term disability when considering
patients who have been medically retired because of various injuries[273][200].
Transfer and engraftment of muscle flap are currently well-established clinical approaches, but
they have many limitations such as donor site morbidity and longer rehabilitation times[242]. This
proposal represents an alternative treatment that can improve the surgical outcome of patients. In
short-term, we will be able to create a complex engineering system that incorporates muscle cell
mimicking nano features, stem cells and growth factor and electrical stimulation that will provide
a competent platform with self-regenerative capacity for muscle regeneration. So far, not many
research groups have been looking at clinically available complex muscle regeneration systems
that are electrically powered. Based on our lab expertise, we will continue to develop a novel
conducting polymer matrices with controlled growth factor release. We will work with clinicians
and surgeons to utilizing electrical stimulation simultaneously treat volumetric muscle loss and
monitor in real-time pathological progression and regression. The high impact of this proposal will
address fundamental issues in musculoskeletal regeneration.
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Electroconductive nanofiber scaffolds for muscle regenerative engineering
Xiaoyan Tang1,2,3, Yusuf Khan1,2,3 ,Cato Laurencin 1,2,3,*,
Institute of Regenerative Engineering, 2 Orthopaedic Surgery, 3 Material Science and Engineering, University of Connecticut,
Storrs, CT
1

Statement of Purpose: Skeletal muscle has the robust ability to
regenerate after minor injury, but is limited in the case of large
volume of muscle loss due to trauma or chronic disease. The
current standard approach for treating volumetric muscle loss
involves either tissue debridement or muscle transposition.
However both procedures present a host of issues such as donor
site morbidity and incomplete recovery of pre-injury muscle
strength and functionality 1. Here we propose a novel, alternative
approach to muscle tissue engineering that has the potential to
restore muscle function in moderate injuries with minimal to no
scar formation but may also offer a regeneration strategy in the
case of large volume muscle loss. Our goal in this study was to
modulate the cellular physical microenvironments to allow
the application of controlled electric impulses via
electroconductive nanofiber scaffolds to generate a more
robust and functional muscle construct for muscle
regeneration.
Material
and
Methods: A
conducting polymer,
poly(3,4ethylenedioxythiophene):poly(styrenesulfonate)
(PEDOT:PSS), was deposited onto surface-modified electrospun
nanofiber matrices (Fig 1) that were formed using a 15 % (w/v)
poly(ε-carprolactone) PCL solution at 2.5 mL/min flow rate, and
1 kV/cm-1 potential at ambient temperature and humidity to
obtain bead-free nanofibers. Then 2mg/ml dopamine was
applied to the surface for 24 hours at pH 8.5 to polymerize onto
the surface of PCL fiber mats to form a polydopamine coating2.
The modified DOPA-PCL surfaces were washed, dried, and
subsequently coated with 1% PEDOT:PSS, 10% PEDOT:PSS,
33% PEDOT:PSS, and 100% PEDOT:PSS solution, where the
100% solution indicates a PEDOT:PSS 1.3wt% dispersion in
H 2O and 33%, 10%, 1% are further diluted with PBS. The dried
scaffolds were treated with mild acid to enhance its
conductivity. Scaffolds were characterized using Scanning
Electron Microscopy (SEM), X-ray photoelectron spectroscopy
(XPS), and contact angle analysis. To determine the in vitro
biocompatibility, C2C12 myoblast cells were cultured on the
substrates. The effects of topographic cues and electrical cues on
cellular morphology, proliferation and myogenic differentiation
were studied using a cell viability assay, live/dead staining, RTPCR (Real-Time Quantitative Reverse Transcription PCR) and
immunohistochemistry 3.
Results and Discussion: Electroconductive nanofiber scaffolds
with tunable conductivity were successfully fabricated. Four
point probe conductivity testing substantiated that the
conductivity could be controlled by modifying the concentration
of PEDOT:PSS applied on scaffolds. The 100% group possessed
an average sheet resistance value of ~5× 10 4, while the
conductivities of the 33% and 10% group were 13× 10 5 and 17×
10 6, respectively. The results of in vitro cell viability assays
suggested that PEDOT:PSS coating exhibited no toxicity.
PEDOT:PSS at 1% and 10% showed stimulatory effect on
C2C12 growth. RT-PCR showed that at 10% PEDOT:PSS,
nanofibers promoted myogenic differentiation as shown by
upregulation of myogenic regulatory factors Myf5,MyoD,
myogenin(MyoG), troponin T type 1(Tnnt1). Fluorescent

images (Fig 2) also shows that addition of conducting polymer
promoted myotube formation.

Conclusions: We have successfully developed a novel method
for fabrication of electroconductive nanofiber scaf-folds.
PEDOT: PSS coating of low and medium concentration(1% and
10%) showed stimulatory effect on C2C12 growth and are more
effective in promoting myoblast differentiation. 10%
PEDOT:PSS promoted myotube formation the most than control
groups. There is a combination of topographical and electrical
guidance cues that have effects on C2C12 differentiation and
need further investigation.
References:
1.Qazi,
T.Biomaterials.
2015;53:502-521.
2.Lee,
H.
Science.2007; 318(5849), 426–30 3.Yang H S. Advanced
healthcare materials. 2015.
Acknowledgements: The authors would like to acknowledge
the National Science Foundation for funding this work
(grant # 1332329)

Figure 1. Schematic illustration of the conducting polymer coated
scaffolds.

Figure 2. Representative fluorescent
images of C2C12 cultured on a) 10%
PEDPT:PSS
coated
scaffolds
b)
Dopamine-PCL scaffolds c) Pure PCL
scaffolds at day 8. Cells were stained for
sarcomere-myosin heavy chain (green) and
nuclei(blue).
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Multifunctional Electroactive Matrices Have the Ability to Promote Muscle Regeneration
Xiaoyan Tang1, 2,3,4 , Yusuf Khan 1, 2,3,4,5 , Cato T. Laurencin 1, 2,3,4,5,6* ,
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and Beverly Sackler Center for Biological, Physical and Engineering Sciences, University of Connecticut Health
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Introduction: The current standard clinical approach to treat muscle volumetric loss is to transfer and
engraft healthy, vascularized, and innervated autologous tissue. However, this method has the issue of
morbidity and there is no total recovery to pre-injury muscle strength and functionality. Therefore, there
is a growing requirement to understand muscle cell behaviour and to fabricate muscle tissues that mimic
native muscle tissue structure. For instance, electrical stimulus is used as one of the ways to stimulate
tissue repair and regeneration. In the area of regenerative engineering, this is mainly done by engineering
smart bioelectronics on conducting polymers as biomaterials, or part of a biomaterial, to provide the
needed electrical stimulus.
Materials and Methods: The multifunctional electroactive matrix consists of the conducting polymer,
poly (3,4ethylenedioxythiophene): poly (styrenesulfonate) (PEDOT: PSS), with a biodegradable
polymer substrate poly (ε-carprolactone) (PCL), which is rationally assembled together. To fabricate this
flexible electroconcondutive scaffold, both aligned and random electrospun nanofiber matrices are
formed using 15 % (w/v) PCL. Then dopamine is applied to the surface for 24 hours at pH 8.5 to
polymerize onto the surface of PCL fiber mats, forming a polydopamine coating. This polydopamine
coating can help to enhance the affinity of PCL fiber mats to muscle cells. Different concentrations of
PEDOT: PSS (1%, 10%, 33%, 100%) were deposited onto surface-modified electrospun nanofiber
matrices. Electroconductive nanofiber scaffolds with tunable conductivity were successfully achieved.
To determine the in vitro biocompatibility, C2C12 myoblast cells were cultured on the substrates. The
effects of topographic cues and electrical cues on cellular morphology, proliferation and myogenic
differentiation were studied using a cell viability assay, live/dead staining, RT-PCR (Real-Time
Quantitative Reverse Transcription PCR) and immunohistochemistry. We further isolated mouse
satellite cells using FACs and cultured them on the scaffolds listed above, then SEM, live/dead staining,
immunohistochemistry were so far used to characterize these scaffolds.
Results and Discussion: Four-point probe conductivity testing substantiated that modifying the
concentration of PEDOT: PSS applied on the matrices could control conductivity. The 100% group
possessed an average sheet resistance value of ~5× 10 4 , while the conductivities of the 33% and 10%
group were 13× 10 5 and 17× 10 6 , respectively. Myotubes were more aligned and organized on the
aligned nanofiber matrices. Further studies demonstrated that these electroactive substrates were
biocompatible both on C2C12 myoblast and mouse satellite cells. They facilitated muscle cell adhesion
and proliferation. Based on study of cultured C2C12 cells, an optimum PEDOT: PSS coating
concentration (10%) was found to be effective in promoting myoblast differentiation due to its intrinsic
conductivity. Mechanistically, differentiation proceeded via an upregulation of myogenic regulatory
factors, Myf5, MyoD, myogenin (MyoG), and troponin T type 1(Tnnt1). Fluorescent images) also shows
that addition of conducting polymer promoted myotube formation.

Figure 1. Schematic illustration of conducting polymer coated
scaffolds

Conclusions: There are topographical and electrical guidance cues that have effects on muscle
differentiation and these studies have helped to elucidate them. This self-responsive bioelectronics matrix
system demonstrated the ability to independently electrically stimulate muscles cells and regulate muscle cell
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A Muscle Regenerative Engineering Strategy for Treating Muscle Atrophy After Chronic Rotator Cuff Tendon
Tear
Xiaoyan Tang1 ,2 ,3 , Mary Badon1,2 , Yusuf Khan1,2 ,3 , Cato T. Laurencin1 ,2 ,3*
1.Institute for Regenerative Engineering, UConn Health, Farmington, CT 06030, USA 2. Department of Orthopedic Surgery, UConn
Health, Farmington, CT 06030, USA 3. Department of Material Science and Engineering, University of Connecticut, Storrs, CT 06269,
USA
Disclosure: The authors have no conflicts of interest to disclose.
Introduction: Rotator cuff tears of the shoulder are the most common and challenging orthopedic problem. Tendon tear not only leads to
pain, but can also cause tendon thinning and retraction, fatty infiltration as well as muscle atrophy, resulting subsequent loss in shoulder
stability and function. Surgical repair of tendon can be performed to restore a strong connection between the bone, tendon, and muscle.
However, commonly there will be delay between the time of injury and surgical repair. This could slow down or inhibit the healing process,
resulting in weak, fatty muscles even after repair. Multiple research groups have been studying the process of muscle atrophy after tendon
tear. In our case, we are studying muscle quality after chronic rotator cuff repair. More importantly, we are proposing there is a positive
effect with implantation of aligned intrinsically conductive muscle scaffolds during surgical repair on supraspinatus muscle. It can act as a
guide and stimulator for muscle regeneration, thus suppressing fatty formation. The incorporation of the scaffolds would result in a higher
level of muscle regeneration and regenerate a morphologically superior enthuses in a rat model of chronic rotator cuff degeneration.
Methods: We previously observed high differentiation of skeletal muscle cells on optimized aligned electrically conductive poly(3,4ethylenedioxythiophene) polystyrene sulfonate (PEDOT: PSS) scaffolds during in vitro. In this study, we have developed a chronic rotator
cuff repair model utilizing adult male Sprague Dawley rats weighing between 400 grams to 450 grams. We first used an open surgical
approach to create a full-thickness rotator cuff tear of supraspinatus tendon. After chronic (42 days) tear, we went back and performed
surgical repair of supraspinatus tendon to 20 animals with or without the insertion of PEDOT: PSS scaffolds at the same time. Briefly,
during tendon repair, a small incision is made through the trapezius muscle at the scapular spine, exposing the midbelly of the
supraspinatus (SS) muscle. Then, a 0.6cm(length)*3 cm (width) PEDOT: PSS scaffold was sutured into the belly of the SS to induce a
cycle of regeneration. Supraspinatus, infraspinatus and control supraspinatus tendon and muscle were exposed and removed for
histological analysis at certain time points after procedure. We then measured changes in muscle mass, tendon length, and the number of
fibers of fast type muscle and slow type muscle. Differences between groups were tested using a one-way ANOVA followed by Tukey’s
post hoc sorting. The surgical groups are listed as follows: Group 1: (control 1) Sham surgery, sacrificed at 2 weeks(n=3) and 6
weeks(n=3). Group 2: (control 2): Rotator cuff acutely injured without repair, sacrificed at week 2(n=4), week 6(n=4). Group 3: Rotator
cuff acutely injured, 6 weeks later repaired with suture, sacrificed at week 2(n=4), week 6(n=6). Group 4: Rotator cuff acutely injured, 6
weeks later repaired with suture and place 10% PEDOT: PSS nanofiber scaffolds on supraspinatus muscle, sacrificed at week 2(n=4),
week 6(n=6)
Results: We used reduced supraspinatus percentage to measure supraspinatus weight loss on the surgical side compared to the nonsurgical
side (Fig. 1). The equations listed as follows: Reduced supraspinatus percentage= (Control supraspinatus weight- surgical supraspinatus
weight)/Control supraspinatus weight. For sham groups, they went through minimal supraspinatus weight loss at 2 weeks compared to
other groups. At six weeks, the wet weight of surgical supraspinatus is higher than control supraspinatus, indicating potential complete
healing of muscle. For tendon tear only groups, the average reduced supraspinatus percentage is statistically greater than other groups (at
least p<0.05) at two weeks as well as six weeks. It is noticeable that after rotator tendon is being repaired, the difference of weight loss
between surgical side and control side is much smaller than tendon tear groups at two weeks and six weeks. However, no significant
difference was observed between chronic repair and chronic repair with scaffold groups in the reduced supraspinatus percentage.
Hematoxylin and eosin staining of the rat supraspinatus muscle (Fig. 2 A-D) demonstrated morphologic changes in the transected rotator
cuff muscle compared to control sham groups. The muscle cross sections were smaller after six weeks tendon tear compared to sham
group, with increased fibrosis of and irregular muscle structure. There are fibrosis present in both chronic repair groups but not as
significant compared with tendon tear only group. The muscle fiber looked organized and compact 6 weeks after successful surgical repair.
(Fig. 2 E) demonstrates fast muscle growth on scaffold, indicating potential muscle regeneration on electrically conductive scaffolds.
Discussion: We have successfully developed rat chronic rotator cuff repair model for our study. It was discovered that even there was a
delay in surgical repair, overall muscle quality such as muscle fiber cross section area and muscle irregularity can be improved, and there
was less fibrosis compared to tendon tear only group. Future study can also be done to explore that delay time between tendon tear and
repair. Also, there were regenerated muscle cells growing on implanted electro conductive scaffolds at 6 weeks after surgical repair,
indicating potential effect of scaffolds stimulating muscle growth following aligned electrospun nano structure.
Significance: In clinical settings, surgical success of a chronic rotator cuff tendon repair is sometimes compromised by muscle quality.
This study showed that in rat chronic rotator cuff model, muscle atrophy can be alleviated by successful surgical repair. Further, with the
evidence of muscle regeneration on scaffolds, there is huge potential that a new class of intrinsic conductive scaffolds can stimulate muscle
growth and suppress fatty infiltration. Muscle regenerative engineering can be a promising clinical treatment in rotator cuff injury.
References: (1) Liu, X.; Manzano, G.; Kim, H. T.; Feeley, B. T. A rat model of massive rotator cuff tears. J. Orthop. Res. 2011, 29 (4),
588–595 DOI: 10.1002/jor.21266. (2)
Barton, E. R.; Gimbel, J. a; Williams, G. R.; Soslowsky, L. J. Rat supraspinatus
muscle atrophy after tendon detachment. J. Orthop. Res. 2005, 23 (2), 259–265 DOI: 10.1016/j.orthres.2004.08.018.
Acknowledgments: The authors would like to acknowledge the NSF EFRI 1332329 and NIH DP1AR068147 and NIH RO1 AR063698
for funding this work. Dr. Laurencin is a recipient of the National Medal of Technology.
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APPENDIX B. SURGERY DETAILS AND PROTOCALS
Surgery procedures
Several sterile instrument packets will be utilized to minimize the repeat use of any instruments.
If necessary, however, the Instrument will be sterilized with the use of a bead sterilizer.
Procedure 1: Rotator cuff tear:
Operative Details:
In all groups only one shoulder will be operated per rat. After the shoulder is adducted, a 1 – 3
cm longitudinal incision will be made with a #15 blade on the lateral border of the acromion to
reflect the skin. An incision will be made along the lateral border to separate the trapezius and
deltoid muscles from the acromion and spine of the scapula. Once the muscle is exposed the
subsequent surgical procedures will vary based on the particular experimental group. Each group
and associated procedure is listed below:
Group 1 - Sham: The rotator cuff tendons will be exposed but left uninjured and the underlying
tissue and skin will be closed (see “Wound Closure” below). Animals will be sacrificed 2, 4, 6,
8, and 12 weeks after the sham procedure.
Group 2 - Full Tendon Tear with no repair: A tunnel will be created in the cortical bone under
the insertion of the supraspinatus tendon. The supraspinatus will then be detached from its
insertion point using a #11 blade. The underlying tissue and skin will be closed (see “Wound
Closure” below).
Group 3, 4, 5, and 6 – Full Tendon Tear with Immediate Matrix Repair:
Tendon tears will be created as described above and repair will have done immediately with
procedure 2, surgical site closed as described below.
Groups 7-14– Full Tendon Tear with Matrix Repair Two weeks, Six Weeks Post Tendon Tear:
Tendon tears will be created as described above and the surgical site closed as described below.
Wound Closure: The muscle and skin layer will be closed with 4-0 vicryl using interrupted
suture technique. The skin layer may be alternatively closed using a subcuticular suturing
technique. Gluture® may be used to seal the edges of the wound. The animal may be placed in a
collar and/or chew guard may be used as a deterrent to prevent the animal from opening the
wound, thus, aid healing. If staples or non-degradable sutures are used in the surgery, they will
be removed 10 – 14 days post-operatively.
Procedure 2: Rotator cuff repair
Rotator cuff repair: At this point, a 5-0 double loaded prolene suture will be introduced into the
supraspinatus muscle and a Masson-Allen or other appropriate stitch sewn into the belly of the
muscle, terminating about 2 – 5 mm from the tendon insertion. The supraspinatus will then be
detached from its insertion point using a #11 blade. A 0.3 – 1.5mm tunnel will be drilled into the
bone as described above without damaging other muscles. The suture will be passed through the
tunnel and tied down to hold the supraspinatus muscle. Concurrently, either a nanofiber matrix or
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surgical reattachment with no matrix will be placed between supraspinatus and subscapularis
muscle.
Group 3, 4, 5, and 6 – Full Tendon Tear with Immediate Matrix Repair: As described above,
immediately after the tendon tear procedure a tunnel will be created in the cortical bone under
the insertion of the supraspinatus tendon. Concurrently, either a PCL nanofiber matrix (group 3),
1% PEDOT: PSS coated PCL matrix (group 4), 10% PEDOT: PSS coated PCL matrix (group 5),
or surgical reattachment with no matrix (group 6) will be placed between supraspinatus and
subscapularis muscle. The defect will then be repaired with No. 5 Prolene tapered needle suture,
approximating the torn tendon back to the humerus and the underlying tissue and skin will be
closed (see “Wound Closure” below).
Groups 7, 8, 9, and 10 – Full Tendon Tear with Matrix Repair Two Weeks Post Tendon Tear:
Two weeks after the tendon tear procedure a tunnel will be created in the cortical bone under the
insertion of the supraspinatus tendon and animals will have matrices implanted and the tendon
reattached as described for groups 3, 4, 5, and 6 and the underlying tissue and skin will be closed
(see “Wound Closure” below). Animals are sacrificed either 2 or 6 weeks after matrix
implantation.
Groups 11, 12, 13, and 14 – Full Tendon Tear with Matrix Repair Six Weeks Post Tendon Tear:
Six weeks after the tendon tear procedure a tunnel will be created in the cortical bone under the
insertion of the supraspinatus tendon and animals will have matrices implanted and the tendon
reattached as described for groups 3, 4, 5, and 6 and the underlying tissue and skin will be closed
(see “Wound Closure” below). Animals are sacrificed either 2 or 6 weeks after matrix
implantation.
Wound Closure: The muscle and skin layer will be closed with 4-0 vicryl using interrupted
suture technique. The skin layer may be alternatively closed using a subcuticular suturing
technique. Gluture® may be used to seal the edges of the wound. The animal may be placed in a
collar and/or chew guard may be used as a deterrent to prevent the animal from opening the
wound, thus, aid healing. If staples or non-degradable sutures are used in the surgery, they will
be removed 10 – 14 days post-operatively.
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Annual Meeting, New Orleans, Louisiana, March 10-13,2018
Tang, X.; Khan, Yusuf; Laurencin, C. T, Oral presentation of "Electroconductive nanofiber matrices for muscle
regenerative engineering" on 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016
Tang, X.; Laurencin, C. T, Oral presentation of abstract titled “Engineered electroactive matrices for muscle
regeneration” at the Biosensors and Bioelectronics Symposium 2016, Stockholm, Sweden, 8/25/2016
Tang, X.; Khan, Yusuf; Laurencin, C. T, Poster presentation of abstract titled" Electroactive Matrices Have the
Ability to Promote Muscle Regeneration" BMES 2016 Annual Meeting, Minneapolis, Minnesota, 10/7/2016
Tang, X.; Khan, Yusuf; Laurencin, C. T, Poster presentation of abstract titled" Conducting Polymer Based Strategy
Towards Muscle Regeneration” 2016 Rock Stars of Regenerative Engineering Conference, Irvine, CA, 12/10/2016

Publications
Tang, X., Thankappan, S.K., Lee, P., Fard, S.E., Harmon, M.D., Tran, K., and Yu, X. (2014). Chapter 21 –
Polymeric Biomaterials in Tissue Engineering and Regenerative Medicine. In Natural and Synthetic Biomedical
Polymers, S.G.K.T.L. Deng, ed. (Oxford: Elsevier), pp. 351-371
Yu, X.; Tang, X.; Gohil, S. V.; Laurencin, C. T. Biomaterials for Bone Regenerative Engineering. Adv. Healthc.
Mater. 2015, 4 (9), 1268–1285 DOI: 10.1002/adhm.201400760.
Tang, X.; Khan.Yusuf; Laurencin, C. T. Electroconductive nanofiber matrices for muscle regenerative engineering
(in submission)
Tang, X.; Guleid, A; Daneshmandi, L; Nair L; Laurencin, C. T. Biomaterial based strategies for skeletal muscle
regeneration (in submission)
Tang, X.; Khan.Yusuf; Laurencin, C. T. Biomaterial based strategies to reduce muscle atrophy in rotator cuff injury
(in prepration)
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